[{"text":"We've extended the deadline for registration to our workshop on conflicts of interests to 28 August: http://t.co/2zGt1S7JOG #coiworkshop","id":"367654864148762624","created_at":"2013-08-14T14:32:04.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/2zGt1S7JOG","expanded_url":"http://bit.ly/14bOWQ3","display_url":"bit.ly/14bOWQ3"}],"hashtags":[{"start":124,"end":136,"tag":"coiworkshop"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367654864148762624","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The 'send a question' form on our website is now working again. We're confident we've recovered all missing messages: http://t.co/pL4pKyZqLQ","id":"367602482853466112","created_at":"2013-08-14T11:03:56.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/pL4pKyZqLQ","expanded_url":"http://bit.ly/16KspMh","display_url":"bit.ly/16KspMh"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367602482853466112","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"From 1 September, active-substance-master-file (#ASMF) holders will only need to submit ASMF dossiers once: http://t.co/ckX3kxvOKY","id":"367602172797923328","created_at":"2013-08-14T11:02:42.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ckX3kxvOKY","expanded_url":"http://bit.ly/13ztmF3","display_url":"bit.ly/13ztmF3"}],"hashtags":[{"start":48,"end":53,"tag":"ASMF"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367602172797923328","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our online 'send a question' form is now working again. Apologies for the inconvenience: http://t.co/pL4pKyZqLQ","id":"367589146346672128","created_at":"2013-08-14T10:10:56.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/pL4pKyZqLQ","expanded_url":"http://bit.ly/16KspMh","display_url":"bit.ly/16KspMh"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367589146346672128","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"New dossier-submission requirements for active-substance master files (ASMFs) come into force on 1 September:  http://t.co/ckX3kxvOKY","id":"367569934844694528","created_at":"2013-08-14T08:54:36.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ckX3kxvOKY","expanded_url":"http://bit.ly/13ztmF3","display_url":"bit.ly/13ztmF3"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":4,"quote_count":0},"conversation_id":"367569934844694528","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA is consulting on guidance to access specialist knowledge for use in risk assessment. Deadline: 30 September.http://t.co/…","id":"367563067728887808","created_at":"2013-08-14T08:27:19.000Z","entities":{"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367563067728887808","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"367562907556384769"}],"attachments":{"media_keys":{}}},{"text":"The EPAR for #Pomalidomide Celgene for the treatment of #multiplemyeloma is now available on our website: http://t.co/rI8Zbj9xq3","id":"367559740010016768","created_at":"2013-08-14T08:14:05.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":13,"end":26,"tag":"Pomalidomide"},{"start":56,"end":72,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"367559740010016768","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @eubookshop: .@EFSA_EU and @ECDC_EU: the #EU report on #antimicrobialresistance and #zoonoses #infections from #animals to #humans http:…","id":"367320220966604800","created_at":"2013-08-13T16:22:19.000Z","entities":{"urls":{},"hashtags":[{"start":44,"end":47,"tag":"EU"},{"start":58,"end":82,"tag":"antimicrobialresistance"},{"start":87,"end":96,"tag":"zoonoses"},{"start":97,"end":108,"tag":"infections"},{"start":114,"end":122,"tag":"animals"},{"start":126,"end":133,"tag":"humans"}],"mentions":[{"start":17,"end":25,"username":"EFSA_EU","id":"84582815"},{"start":30,"end":38,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367320220966604800","source":"Twitter for iPhone","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"367315536440733696"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Pomalidomide Celgene for the treatment of #multiplemyeloma http://t.co/rI8Zbj9xq3","id":"367278045172080641","created_at":"2013-08-13T13:34:44.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":42,"end":55,"tag":"Pomalidomide"},{"start":85,"end":101,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"367278045172080641","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Reusken study in @TheLancet very useful but does not prove camels are the source of human #MERS-CoV infection: http://t.co/7k…","id":"367276854392406016","created_at":"2013-08-13T13:30:00.000Z","entities":{"urls":{},"hashtags":[{"start":104,"end":109,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":31,"end":41,"username":"TheLancet","id":"27013292"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367276854392406016","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"367276488564801538"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: The #FDA approves #Tivicay (dolutegravir), a new drug to treat HIV-1 infection: http://t.co/LNRzGeg6RF.","id":"367276576888848384","created_at":"2013-08-13T13:28:54.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/LNRzGeg6RF","expanded_url":"http://1.usa.gov/13xluUD","display_url":"1.usa.gov/13xluUD"}],"hashtags":[{"start":23,"end":27,"tag":"FDA"},{"start":37,"end":45,"tag":"Tivicay"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":82,"end":84,"probability":0.6332,"type":"Other","normalized_text":"HIV"}]},"public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367276576888848384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"367272211754663937"}],"attachments":{"media_keys":{}}},{"text":"Send us your comments on our draft #herbal monograph on the use of #Eucalyptus. Consultation open until 15 November: http://t.co/xfBkJ4KXpD","id":"367239725095976961","created_at":"2013-08-13T11:02:28.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/xfBkJ4KXpD","expanded_url":"http://bit.ly/13UYfXW","display_url":"bit.ly/13UYfXW"}],"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":67,"end":78,"tag":"Eucalyptus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367239725095976961","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on a new model of disease progression and trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","id":"367239446342541312","created_at":"2013-08-13T11:01:21.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":88,"end":98,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"367239446342541312","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: In a series of blogs on the EFPIA-PhRMA Commitments, EFPIA DG Richard Bergstrom speaks about each of the Commitments http://t.co…","id":"367222258437480448","created_at":"2013-08-13T09:53:03.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":73,"end":89,"probability":0.5444,"type":"Person","normalized_text":"Richard Bergstrom"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367222258437480448","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"367209313778937857"}],"attachments":{"media_keys":{}}},{"text":"Our draft monograph on the use of #Eucalyptus is open for consultation until 15 November: http://t.co/eWLIKXI7bC","id":"367204069854965760","created_at":"2013-08-13T08:40:47.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/eWLIKXI7bC","expanded_url":"http://bit.ly/13UYfXW","display_url":"bit.ly/13UYfXW"}],"hashtags":[{"start":34,"end":45,"tag":"Eucalyptus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367204069854965760","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Send us your comments on our inventory of #paediatric needs in #nephrourology: consultation open until 14 November: http://t.co/YR2ts17Q2P","id":"367202918207733761","created_at":"2013-08-13T08:36:12.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/YR2ts17Q2P","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":42,"end":53,"tag":"paediatric"},{"start":63,"end":77,"tag":"nephrourology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"367202918207733761","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Atosiban SUN is available on our website - a #generic of #Tractocile to delay #preterm birth: http://t.co/dLARFKhpXB","id":"367202682148093952","created_at":"2013-08-13T08:35:16.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/dLARFKhpXB","expanded_url":"http://bit.ly/15uF2bu","display_url":"bit.ly/15uF2bu"}],"hashtags":[{"start":13,"end":22,"tag":"Atosiban"},{"start":59,"end":67,"tag":"generic"},{"start":71,"end":82,"tag":"Tractocile"},{"start":92,"end":100,"tag":"preterm"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"367202682148093952","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks to comment on our opinion on a new model of disease progression &amp; trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","id":"367202214659358720","created_at":"2013-08-13T08:33:24.000Z","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":100,"end":110,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"367202214659358720","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Drug Safety Update, Volume 7 Issue 1 (August 2013) http://t.co/lUwvSj52Ud","id":"366952014552367104","created_at":"2013-08-12T15:59:12.000Z","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/lUwvSj52Ud","expanded_url":"http://tinyurl.com/jwsa8at","display_url":"tinyurl.com/jwsa8at"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366952014552367104","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366951862739546113"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Updated Listing of Approved Medicated #Feed Mill Licenses http://t.co/t4rHUI8PDG","id":"366942598214066178","created_at":"2013-08-12T15:21:47.000Z","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/t4rHUI8PDG","expanded_url":"http://bit.ly/9h7CkO","display_url":"bit.ly/9h7CkO"}],"hashtags":[{"start":59,"end":64,"tag":"Feed"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366942598214066178","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366942475820072961"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA announces nationwide voluntary recall of all products for sterile use from Specialty Compounding: http://t.co/wqUF2…","id":"366941855113428992","created_at":"2013-08-12T15:18:50.000Z","entities":{"urls":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":99,"end":119,"probability":0.6596,"type":"Organization","normalized_text":"Specialty Compounding"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366941855113428992","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366941795940171777"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Atosiban SUN, a #generic of #Tractocile to delay #preterm birth: http://t.co/dLARFKhpXB","id":"366935316487090177","created_at":"2013-08-12T14:52:51.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/dLARFKhpXB","expanded_url":"http://bit.ly/15uF2bu","display_url":"bit.ly/15uF2bu"}],"hashtags":[{"start":42,"end":51,"tag":"Atosiban"},{"start":59,"end":67,"tag":"generic"},{"start":71,"end":82,"tag":"Tractocile"},{"start":92,"end":100,"tag":"preterm"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366935316487090177","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @FDAMedWatch: July 2013 Safety Labeling Changes from MedWatch includes 34 products with revisions to Prescribing Information http://t.co…","id":"366913684724920320","created_at":"2013-08-12T13:26:54.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":[{"start":56,"end":63,"probability":0.8307,"type":"Organization","normalized_text":"MedWatch"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366913684724920320","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366913453023166465"}],"attachments":{"media_keys":{}}},{"text":"RT @IlaeWeb: Call for comments on new definition of Epilepsy created by ILAE: http://t.co/oTBJ6J6EWf","id":"366911406408335361","created_at":"2013-08-12T13:17:50.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/oTBJ6J6EWf","expanded_url":"http://www.ilae.org/Visitors/Centre/Definition.cfm","display_url":"ilae.org/Visitors/Centr…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366911406408335361","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366906769462669313"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Diabetologia | Improved genetic testing for monogenic diabetes using targeted next-generation sequencing http://t.co/tHsgSlx0yv","id":"366883843149533185","created_at":"2013-08-12T11:28:19.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/tHsgSlx0yv","expanded_url":"http://link.springer.com/article/10.1007/s00125-013-2962-5","display_url":"link.springer.com/article/10.100…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366883843149533185","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366883669190782977"}],"attachments":{"media_keys":{}}},{"text":"We've published an inventory of #paediatric needs in #nephrourology for consultation until 14 November: http://t.co/YR2ts17Q2P","id":"366877164269862913","created_at":"2013-08-12T11:01:46.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/YR2ts17Q2P","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":32,"end":43,"tag":"paediatric"},{"start":53,"end":67,"tag":"nephrourology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366877164269862913","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"European pharma industry stages workshop to consider practical issues involved in clinical trials data transparency\" http://t.c…","id":"366876437489262594","created_at":"2013-08-12T10:58:53.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366876437489262594","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366875607839150082"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: Improved genetic testing for monogenic diabetes using targeted next-generation sequencing - http://t.co/icvQPELXLB","id":"366861053293887488","created_at":"2013-08-12T09:57:45.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/icvQPELXLB","expanded_url":"http://goo.gl/KfkhrJ","display_url":"goo.gl/KfkhrJ"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366861053293887488","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366860909127270400"}],"attachments":{"media_keys":{}}},{"text":"RT @HepatitisEurope: Can combination oral antivirals for #liverpatients become unnecessary for chronic #HBV infection? http://t.co/epAXKauP…","id":"366859023678578688","created_at":"2013-08-12T09:49:41.000Z","entities":{"urls":{},"hashtags":[{"start":57,"end":71,"tag":"liverpatients"},{"start":103,"end":107,"tag":"HBV"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366859023678578688","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"366858866698362880"}],"attachments":{"media_keys":{}}},{"text":"If you've sent us a question using our online form, please resend to info@ema.europa.eu if you haven't had a reply: http://t.co/8nLMmsOqpJ","id":"366842635446525953","created_at":"2013-08-12T08:44:34.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/8nLMmsOqpJ","expanded_url":"http://bit.ly/13LPkrU","display_url":"bit.ly/13LPkrU"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"366842635446525953","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: First reported #westnile case in Italy, updated ECDC maps now online: http://t.co/UWKpvidcrC See infographic: http://t.co/V3S0…","id":"365851001804169217","created_at":"2013-08-09T15:04:10.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/UWKpvidcrC","expanded_url":"http://bit.ly/QijONt","display_url":"bit.ly/QijONt"}],"hashtags":[{"start":28,"end":37,"tag":"westnile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":46,"end":50,"probability":0.9913,"type":"Place","normalized_text":"Italy"}]},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365851001804169217","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365849139927461889"}],"attachments":{"media_keys":{}}},{"text":"Our 'send a question' form has not been working for a few weeks. Use info@ema.europa.eu to resend &amp; for new queries: http://t.co/8nLMmsOqpJ","id":"365849844075601920","created_at":"2013-08-09T14:59:34.000Z","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/8nLMmsOqpJ","expanded_url":"http://bit.ly/13LPkrU","display_url":"bit.ly/13LPkrU"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365849844075601920","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: Read our thoughts on EFPIA's recently posted YouTube video 'Clinical Trials &amp; Transparency' http://t.co/Qaa2m8Cz3X","id":"365834313993961473","created_at":"2013-08-09T13:57:52.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Qaa2m8Cz3X","expanded_url":"http://bit.ly/1aaVPYX","display_url":"bit.ly/1aaVPYX"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":60,"end":66,"probability":0.5354,"type":"Organization","normalized_text":"YouTube"},{"start":75,"end":104,"probability":0.5391,"type":"Other","normalized_text":"Clinical Trials & Transparency"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365834313993961473","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365834105901940736"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Study reporting #MERS antibodies in camels doesn't change ECDC’s assessment:pandemic potential of #MERS-CoV still low http://t…","id":"365833258644156418","created_at":"2013-08-09T13:53:40.000Z","entities":{"urls":{},"hashtags":[{"start":29,"end":34,"tag":"MERS"},{"start":111,"end":116,"tag":"MERS"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365833258644156418","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365832807370588160"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Middle East respiratory syndrome antibodies found in camels - what does it mean? http://t.co/oKnCGkvwpm #MERS #coronavirus","id":"365773083618971648","created_at":"2013-08-09T09:54:33.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/oKnCGkvwpm","expanded_url":"http://goo.gl/BEXnpV","display_url":"goo.gl/BEXnpV"}],"hashtags":[{"start":113,"end":118,"tag":"MERS"},{"start":119,"end":131,"tag":"coronavirus"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":150,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365773083618971648","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365773015369256961"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: UPDATED Frequently Asked Questions on Middle East respiratory syndrome http://t.co/oKnCGkvwpm #MERS #coronavirus","id":"365771521371148288","created_at":"2013-08-09T09:48:21.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/oKnCGkvwpm","expanded_url":"http://goo.gl/BEXnpV","display_url":"goo.gl/BEXnpV"}],"hashtags":[{"start":103,"end":108,"tag":"MERS"},{"start":109,"end":121,"tag":"coronavirus"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365771521371148288","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365771301224333312"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Genes That Drive #Brain #Cancer Revealed http://t.co/qpKTCYL9nG","id":"365766739910340608","created_at":"2013-08-09T09:29:21.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/qpKTCYL9nG","expanded_url":"http://bit.ly/16vmeNU","display_url":"bit.ly/16vmeNU"}],"hashtags":[{"start":28,"end":34,"tag":"Brain"},{"start":35,"end":42,"tag":"Cancer"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365766739910340608","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365766182797705217"}],"attachments":{"media_keys":{}}},{"text":"RT @my_ueg: #AllTrials has published a statement on the registration and reporting of all clinical #trials http://t.co/DiXUEToKVM  @Alltria…","id":"365758419459784707","created_at":"2013-08-09T08:56:17.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/DiXUEToKVM","expanded_url":"http://bit.ly/170kCtB","display_url":"bit.ly/170kCtB"}],"hashtags":[{"start":12,"end":22,"tag":"AllTrials"},{"start":99,"end":106,"tag":"trials"}],"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365758419459784707","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365757018679676931"}],"attachments":{"media_keys":{}}},{"text":"Send us your comments on our note on the withdrawal of guidance on #influenza #vaccines: http://t.co/4lnyicSRX3","id":"365752464533757952","created_at":"2013-08-09T08:32:37.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/4lnyicSRX3","expanded_url":"http://bit.ly/18doloM","display_url":"bit.ly/18doloM"}],"hashtags":[{"start":67,"end":77,"tag":"influenza"},{"start":78,"end":87,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365752464533757952","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published our finalised guideline on the pharmaceutical development of medicines for #paediatric use: http://t.co/rJ15XFJH72","id":"365752292487593984","created_at":"2013-08-09T08:31:56.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/rJ15XFJH72","expanded_url":"http://bit.ly/11OPlKp","display_url":"bit.ly/11OPlKp"}],"hashtags":[{"start":91,"end":102,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"365752292487593984","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Send us your comments on our concept paper on revising our condition-specific guidance for anti-#cancer medicines: http://t.co/PYec7oZSQT","id":"365751700205744128","created_at":"2013-08-09T08:29:35.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/PYec7oZSQT","expanded_url":"http://bit.ly/13ICHxJ","display_url":"bit.ly/13ICHxJ"}],"hashtags":[{"start":96,"end":103,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365751700205744128","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Pheburane (sodium #phenylbutyrate) for #ureacycle disorders is available on our website: http://t.co/ab0bHu70PY","id":"365751524602818561","created_at":"2013-08-09T08:28:53.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/ab0bHu70PY","expanded_url":"http://bit.ly/1cMwdRU","display_url":"bit.ly/1cMwdRU"}],"hashtags":[{"start":13,"end":23,"tag":"Pheburane"},{"start":32,"end":47,"tag":"phenylbutyrate"},{"start":53,"end":63,"tag":"ureacycle"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"365751524602818561","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"A public consultation is open on our note on the withdrawal of guidance on #influenza #vaccines: http://t.co/4lnyicSRX3","id":"365483422984048641","created_at":"2013-08-08T14:43:33.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/4lnyicSRX3","expanded_url":"http://bit.ly/18doloM","display_url":"bit.ly/18doloM"}],"hashtags":[{"start":75,"end":85,"tag":"influenza"},{"start":86,"end":95,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"365483422984048641","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our guideline on the pharmaceutical development of medicines for #paediatric use is available:http://t.co/rJ15XFJH72","id":"365479746554961921","created_at":"2013-08-08T14:28:56.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/rJ15XFJH72","expanded_url":"http://bit.ly/11OPlKp","display_url":"bit.ly/11OPlKp"}],"hashtags":[{"start":65,"end":76,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"365479746554961921","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've released a concept paper on revising condition-specific guidance for anti-#cancer medicines for consultation: http://t.co/PYec7oZSQT","id":"365436220626575363","created_at":"2013-08-08T11:35:59.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/PYec7oZSQT","expanded_url":"http://bit.ly/13ICHxJ","display_url":"bit.ly/13ICHxJ"}],"hashtags":[{"start":80,"end":87,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"365436220626575363","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Pheburane (sodium #phenylbutyrate) for #ureacycle disorders: http://t.co/ab0bHu70PY","id":"365430023672446976","created_at":"2013-08-08T11:11:21.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/ab0bHu70PY","expanded_url":"http://bit.ly/1cMwdRU","display_url":"bit.ly/1cMwdRU"}],"hashtags":[{"start":42,"end":52,"tag":"Pheburane"},{"start":61,"end":76,"tag":"phenylbutyrate"},{"start":82,"end":92,"tag":"ureacycle"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"365430023672446976","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The guideline on combined #vaccines and associations of #immunological #veterinary #medicines is on our website: http://t.co/jjRl5WqmSv","id":"365429368899641346","created_at":"2013-08-08T11:08:45.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/jjRl5WqmSv","expanded_url":"http://bit.ly/1c675GV","display_url":"bit.ly/1c675GV"}],"hashtags":[{"start":26,"end":35,"tag":"vaccines"},{"start":56,"end":70,"tag":"immunological"},{"start":71,"end":82,"tag":"veterinary"},{"start":83,"end":93,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365429368899641346","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Clinical Trials and Transparency | EFPIA http://t.co/H1SSxA0VLS","id":"365410670692405248","created_at":"2013-08-08T09:54:27.000Z","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/H1SSxA0VLS","expanded_url":"http://youtu.be/1qCUHRNmrZ4","display_url":"youtu.be/1qCUHRNmrZ4"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365410670692405248","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365409776030580736"}],"attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Good pharmacovigilance practices for veterinary medicines http://t.co/TKWThpD61v","id":"365409214216146944","created_at":"2013-08-08T09:48:40.000Z","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/TKWThpD61v","expanded_url":"http://www.aemps.gob.es/vigilancia/medicamentosVeterinarios/docs/bp_fv_vet_agosto2013.pdf","display_url":"aemps.gob.es/vigilancia/med…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"365409214216146944","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Upcoming data sharing workshop 'opportunity to bring different opinions to 1 table' EFPIA DG Richard Bergstrom blogs http://t.co…","id":"365402666421452800","created_at":"2013-08-08T09:22:39.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":104,"end":120,"probability":0.7538,"type":"Person","normalized_text":"Richard Bergstrom"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365402666421452800","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365402487785668608"}],"attachments":{"media_keys":{}}},{"text":"Our guideline on combined #vaccines and associations of #immunological #veterinary #medicines is available: http://t.co/jjRl5WqmSv","id":"365389441713446912","created_at":"2013-08-08T08:30:06.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/jjRl5WqmSv","expanded_url":"http://bit.ly/1c675GV","display_url":"bit.ly/1c675GV"}],"hashtags":[{"start":26,"end":35,"tag":"vaccines"},{"start":56,"end":70,"tag":"immunological"},{"start":71,"end":82,"tag":"veterinary"},{"start":83,"end":93,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"365389441713446912","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: IMI’s #autism project EU-AIMS is featured in the @guardiansciblog today http://t.co/KCnQb33Ys5","id":"365131878883684352","created_at":"2013-08-07T15:26:38.000Z","entities":{"urls":{},"hashtags":[{"start":18,"end":25,"tag":"autism"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365131878883684352","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365131662587215872"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Injectable 'smart sponge' holds promise for controlled drug delivery:\nhttp://t.co/pVf36sxfse","id":"365124773023875072","created_at":"2013-08-07T14:58:24.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/pVf36sxfse","expanded_url":"http://www.worldpharmanews.com/research/2512-injectable-smart-sponge-holds-promise-for-controlled-drug-delivery","display_url":"worldpharmanews.com/research/2512-…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365124773023875072","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365121760980516865"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'Injectable 'smart sponge' holds promise for controlled drug delivery' - #diabetes news #innovation http://t.co/tPS3nBwko7","id":"365097531900174336","created_at":"2013-08-07T13:10:09.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/tPS3nBwko7","expanded_url":"http://bit.ly/12ZOysK","display_url":"bit.ly/12ZOysK"}],"hashtags":[{"start":84,"end":93,"tag":"diabetes"},{"start":99,"end":110,"tag":"innovation"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365097531900174336","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365080547460005891"}],"attachments":{"media_keys":{}}},{"text":"RT @eurordis: CEO Yann Le Cam and the EPIRARE project on the importance of #patient participation in #RareDisease registries http://t.co/r2…","id":"365097207470772224","created_at":"2013-08-07T13:08:52.000Z","entities":{"urls":{},"hashtags":[{"start":75,"end":83,"tag":"patient"},{"start":101,"end":113,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":18,"end":28,"probability":0.4502,"type":"Person","normalized_text":"Yann Le Cam"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"365097207470772224","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"365068973835943936"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: Drug development is a five-step process. Learn about the different phases that keep medicine safe and effective: http://t.co/…","id":"364771063169040384","created_at":"2013-08-06T15:32:53.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364771063169040384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364770948899016705"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: CVM's #Drug Shortage page has been updated, http://t.co/vyWpR16J89","id":"364756390587682816","created_at":"2013-08-06T14:34:35.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/vyWpR16J89","expanded_url":"http://1.usa.gov/rFB5W0","display_url":"1.usa.gov/rFB5W0"}],"hashtags":[{"start":27,"end":32,"tag":"Drug"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364756390587682816","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364755911618736128"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: #FDAVoice: New Drugs Reach Patients at a Constant Rate: New FDA Study Reports on 25-yr record of approvals. http://t.co/dJ7sM2H…","id":"364735005144395776","created_at":"2013-08-06T13:09:36.000Z","entities":{"urls":{},"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364735005144395776","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364731774040944642"}],"attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Medical investigators http://t.co/uw8cm2eDwI #newjob","id":"364724153229647873","created_at":"2013-08-06T12:26:29.000Z","entities":{"urls":[{"start":34,"end":56,"url":"http://t.co/uw8cm2eDwI","expanded_url":"http://bit.ly/1545gBB","display_url":"bit.ly/1545gBB"}],"hashtags":[{"start":57,"end":64,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364724153229647873","source":"TweetDeck","lang":"ca","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA | Human medicines highlights - Issue 54 - July 2013 is now available: http://t.co/QWV4ZHx3nL","id":"364699355028422656","created_at":"2013-08-06T10:47:56.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/QWV4ZHx3nL","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2013/08/WC500147208.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364699355028422656","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364699255551700993"}],"attachments":{"media_keys":{}}},{"text":"RT @eurordis: Video about research into #raredisease #cystinosis at @sunderlanduni incl interview with Roy Forsyth of @CystinosisUK http://…","id":"364691452112404480","created_at":"2013-08-06T10:16:32.000Z","entities":{"urls":{},"hashtags":[{"start":40,"end":52,"tag":"raredisease"},{"start":53,"end":64,"tag":"cystinosis"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":68,"end":82,"username":"sunderlanduni","id":"119669630"},{"start":118,"end":131,"username":"CystinosisUK","id":"476980253"}],"annotations":[{"start":103,"end":113,"probability":0.9526,"type":"Person","normalized_text":"Roy Forsyth"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364691452112404480","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364683382820581378"}],"attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Human medicines highlights - Issue 54 - July 2013 http://t.co/NvXlbJX70A","id":"364689302976225280","created_at":"2013-08-06T10:08:00.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/NvXlbJX70A","expanded_url":"http://bit.ly/13XbMJX","display_url":"bit.ly/13XbMJX"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364689302976225280","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364682410668998656"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: Eur. Med. Agency recommends granting mkting aut. for Filgrastim (Grastofil) for the treatment of #neutropenia http://t.co/bB8fs…","id":"364689232113451008","created_at":"2013-08-06T10:07:43.000Z","entities":{"urls":{},"hashtags":[{"start":109,"end":121,"tag":"neutropenia"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364689232113451008","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364681887874158592"}],"attachments":{"media_keys":{}}},{"text":"RT @my_ueg: Watch and learn about latest advances in diagnosis and treatment of hepato-pancreato-biliary malignancies:http://t.co/rhv47fcJa…","id":"364669792059666432","created_at":"2013-08-06T08:50:28.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364669792059666432","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364669023331426304"}],"attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: Projects FP7, a public list by #CORDIS https://t.co/DLg5JZoYcK","id":"364419932865720320","created_at":"2013-08-05T16:17:37.000Z","entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/DLg5JZoYcK","expanded_url":"https://twitter.com/myCORDIS/projects-fp7","display_url":"twitter.com/myCORDIS/proje…"}],"hashtags":[{"start":45,"end":52,"tag":"CORDIS"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364419932865720320","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364419496057896961"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: #Animal drug approvals for August 2013 http://t.co/UjNM4rQJi4","id":"364406119202291712","created_at":"2013-08-05T15:22:43.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/UjNM4rQJi4","expanded_url":"http://1.usa.gov/1bSIztI","display_url":"1.usa.gov/1bSIztI"}],"hashtags":[{"start":21,"end":28,"tag":"Animal"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364406119202291712","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364405904575180800"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: It may be low season for #flu but @ECDC_EU still produces its surveillance overview. Here's the latest issue: http://t.co/eP0…","id":"364404249469657088","created_at":"2013-08-05T15:15:18.000Z","entities":{"urls":{},"hashtags":[{"start":39,"end":43,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":48,"end":56,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364404249469657088","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364404176320606209"}],"attachments":{"media_keys":{}}},{"text":"RT @borgton: We can reduce deaths from overuse and abuse of anti microbial agents. EC action plan needs to be implemented by Member States","id":"364401078814916608","created_at":"2013-08-05T15:02:42.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":[{"start":125,"end":137,"probability":0.4099,"type":"Organization","normalized_text":"Member States"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364401078814916608","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364392621651034112"}],"attachments":{"media_keys":{}}},{"text":"RT @borgton: Anti Microbial Resistance abuse and overuse of anti microbial agents result in 25000 deaths each year in the EU .","id":"364401053607157760","created_at":"2013-08-05T15:02:36.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364401053607157760","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364392286668742656"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'EC sets up expert group on rare diseases' - http://t.co/FcI6vzar0p","id":"364400839173353472","created_at":"2013-08-05T15:01:44.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/FcI6vzar0p","expanded_url":"http://bit.ly/13rLALW","display_url":"bit.ly/13rLALW"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364400839173353472","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364386513687035905"}],"attachments":{"media_keys":{}}},{"text":"This morning we updated our guidance on the #validation process for initial marketing authorisations: http://t.co/xOmYpi4Zkx","id":"364376255572873216","created_at":"2013-08-05T13:24:03.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/xOmYpi4Zkx","expanded_url":"http://bit.ly/13eIszI","display_url":"bit.ly/13eIszI"}],"hashtags":[{"start":44,"end":55,"tag":"validation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364376255572873216","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @GCessak: August 4th, 2013, entered into force Commission Regulation (EU) No. 712/2012 of 3 August 2012 http://t.co/2hTYGmwcfT","id":"364375991990624256","created_at":"2013-08-05T13:23:00.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/2hTYGmwcfT","expanded_url":"http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:209:0004:0014:EN:PDF","display_url":"eur-lex.europa.eu/LexUriServ/Lex…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364375991990624256","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364372891187412992"}],"attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Last week @US_FDA announced that acetaminophen is linked to rare, serious skin reactions, following a review of ADRs http://…","id":"364375562200297472","created_at":"2013-08-05T13:21:18.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":25,"end":32,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364375562200297472","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364360659011514368"}],"attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Concerning news on antibiotic resistance http://t.co/pzJmMeMfCA &lt;HPs have crucial role in antimicrobial stewardship http://t…","id":"364375453462970368","created_at":"2013-08-05T13:20:52.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/pzJmMeMfCA","expanded_url":"http://theconversation.com/catastrophic-threat-looms-as-superbug-beats-another-antibiotic-12950","display_url":"theconversation.com/catastrophic-t…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"364375453462970368","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"364360189970874368"}],"attachments":{"media_keys":{}}},{"text":"We've published guidance on the #validation process for initial marketing authorisations: http://t.co/sv8R6JkPA5","id":"364329684139778048","created_at":"2013-08-05T10:19:00.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/sv8R6JkPA5","expanded_url":"http://bit.ly/13eIszI","display_url":"bit.ly/13eIszI"}],"hashtags":[{"start":32,"end":43,"tag":"validation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"364329684139778048","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: The MHRA are seeking views on the European Commission's proposal for fees for pharmacovigilance payable to the EMA http:…","id":"363317125190270976","created_at":"2013-08-02T15:15:27.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363317125190270976","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363316606186700800"}],"attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Announcing the October 22-23, 2013 Cellular, Tissue &amp; Gene Therapies Advisory Committee Mtg. Details available at: http://t.co…","id":"363311658196029440","created_at":"2013-08-02T14:53:44.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":[{"start":58,"end":103,"probability":0.4987,"type":"Organization","normalized_text":"Tissue & Gene Therapies Advisory Committee Mtg"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363311658196029440","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363311071773212674"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Latest weekly #WestNile maps now online: http://t.co/UWKpvidcrC See infographic: http://t.co/YYQBgzLPVw","id":"363311610569687040","created_at":"2013-08-02T14:53:32.000Z","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/UWKpvidcrC","expanded_url":"http://bit.ly/QijONt","display_url":"bit.ly/QijONt"},{"start":94,"end":116,"url":"http://t.co/YYQBgzLPVw","expanded_url":"https://twitter.com/ECDC_EU/status/363310435719602176/photo/1","display_url":"pic.twitter.com/YYQBgzLPVw"}],"hashtags":[{"start":27,"end":36,"tag":"WestNile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363311610569687040","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363310435719602176"}],"attachments":{"media_keys":["3_363310435723796480"]}},{"text":"RT @FDAanimalhealth: Domestic &amp; Foreign Facility Reinspection, Recall, &amp; Importer Reinspection Fee Rates, Fiscal Year 2014 http://t.co/bgFT…","id":"363311168079015936","created_at":"2013-08-02T14:51:47.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363311168079015936","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363297148479082497"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA Announces Fiscal Year 2014 Generic Drug Fees #GDUFA http://t.co/FN1bFMW54D","id":"363311106015891456","created_at":"2013-08-02T14:51:32.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/FN1bFMW54D","expanded_url":"http://1.usa.gov/14nUkFF","display_url":"1.usa.gov/14nUkFF"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":69,"end":75,"tag":"GDUFA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363311106015891456","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363291490547544064"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Learn about flu virus characterisation over the 2012/13 season by reading the latest ERLI-Net report: http://t.co/lWeydvc0Cn","id":"363310766558294016","created_at":"2013-08-02T14:50:11.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/lWeydvc0Cn","expanded_url":"http://bit.ly/11za3xM","display_url":"bit.ly/11za3xM"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363310766558294016","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363274537837670400"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: Have you seen our new section on #EGFRI-related Skin Toxicity? Info for patients &amp; HCPs http://t.co/DJKxu5j34O #OncologyPRO","id":"363290655931789312","created_at":"2013-08-02T13:30:16.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/DJKxu5j34O","expanded_url":"http://ow.ly/nzgje","display_url":"ow.ly/nzgje"}],"hashtags":[{"start":45,"end":51,"tag":"EGFRI"},{"start":127,"end":139,"tag":"OncologyPRO"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363290655931789312","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363268968494018560"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Get it while it's fresh: EFPIA's latest newsletter is here! http://t.co/suqlngCbQ2","id":"363264106117464064","created_at":"2013-08-02T11:44:46.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/suqlngCbQ2","expanded_url":"http://bit.ly/12L6dEC","display_url":"bit.ly/12L6dEC"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363264106117464064","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363264016178618368"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Promote #ESCAIDE, add the 2013 banner to your website: http://t.co/EfecIBgD7O http://t.co/6F1hy3ZDZm","id":"363263910495141888","created_at":"2013-08-02T11:44:00.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/EfecIBgD7O","expanded_url":"http://bit.ly/QZrjGH","display_url":"bit.ly/QZrjGH"},{"start":91,"end":113,"url":"http://t.co/6F1hy3ZDZm","expanded_url":"https://twitter.com/ECDC_EU/status/363262301639409664/photo/1","display_url":"pic.twitter.com/6F1hy3ZDZm"}],"hashtags":[{"start":21,"end":29,"tag":"ESCAIDE"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363263910495141888","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363262301639409664"}],"attachments":{"media_keys":["3_363262301643603968"]}},{"text":"Just a few days left to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"363253163580604416","created_at":"2013-08-02T11:01:17.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":50,"end":68,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"363253163580604416","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Just a few days left to comment on our #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"363253078763380737","created_at":"2013-08-02T11:00:57.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363253078763380737","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @HepatitisEurope: Engineered mice act as #hepatitis C model, will this lead to a new #vaccine?  http://t.co/KZ6TQVlheQ","id":"363239844132425728","created_at":"2013-08-02T10:08:22.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/KZ6TQVlheQ","expanded_url":"http://www.nature.com/news/engineered-mice-act-as-hepatitis-c-model-1.13477","display_url":"nature.com/news/engineere…"}],"hashtags":[{"start":44,"end":54,"tag":"hepatitis"},{"start":88,"end":96,"tag":"vaccine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363239844132425728","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363224808755961856"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"Let's keep the conversation going\" EFPIA DG Richard Bergstrom blogs on rxn to EFPIA @PhRMA data-sharing commitments http://t.co…","id":"363219565142343680","created_at":"2013-08-02T08:47:47.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":96,"end":102,"username":"PhRMA","id":"116748080"}],"annotations":[{"start":56,"end":72,"probability":0.477,"type":"Person","normalized_text":"Richard Bergstrom"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363219565142343680","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363219328792924160"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: The European Commission's decision was published for the medicinal product Diane 35 and its generics: http://t.co/YMMZnCOf9H","id":"363219447664091136","created_at":"2013-08-02T08:47:19.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/YMMZnCOf9H","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-2-sierpnia-2013-r-po-ukazaniu-sie-decyzji-komisji-europejskiej-w-sprawie-produktu-leczniczego-diane-35-i-jego-odpowie","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":88,"end":95,"probability":0.4625,"type":"Person","normalized_text":"Diane 35"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363219447664091136","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"363218705645182977"}],"attachments":{"media_keys":{}}},{"text":"Send us your comments on our guideline on medicines for the treatment of amyotrophic lateral sclerosis (#ALS): http://t.co/w3dPAKnzED","id":"363210921201504256","created_at":"2013-08-02T08:13:26.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/w3dPAKnzED","expanded_url":"http://bit.ly/13DJIeH","display_url":"bit.ly/13DJIeH"}],"hashtags":[{"start":104,"end":108,"tag":"ALS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363210921201504256","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Send us your comments on our concept paper on development of product-specific guidance on #bioequivalence: http://t.co/eISk9bSd8U","id":"363210354668474368","created_at":"2013-08-02T08:11:11.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":90,"end":105,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"363210354668474368","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Ourconsultation on a novel model of disease progression &amp; trial evaluation in #Alzheimer's disease is running: http://t.co/Izrc2TPeTV","id":"363210086635667457","created_at":"2013-08-02T08:10:07.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":82,"end":92,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363210086635667457","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"In September, we're going to start using digital signatures for some documents: http://t.co/MD4au6ypdA","id":"363209886277976066","created_at":"2013-08-02T08:09:19.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/MD4au6ypdA","expanded_url":"http://bit.ly/15ftKO7","display_url":"bit.ly/15ftKO7"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"363209886277976066","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our plans for reorganising the Agency are progressing well: http://t.co/Gi1YpaqP8b","id":"363209738672017408","created_at":"2013-08-02T08:08:44.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/Gi1YpaqP8b","expanded_url":"http://bit.ly/16lLHsY","display_url":"bit.ly/16lLHsY"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"363209738672017408","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"363209240183181312","created_at":"2013-08-02T08:06:45.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"363209240183181312","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on our draft #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"363209158134214656","created_at":"2013-08-02T08:06:26.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"363209158134214656","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@wombarrapete We are evaluating the results of the investigations done by Clinuvel. We will publish the outcome once this is complete.","id":"363208541962002432","created_at":"2013-08-02T08:03:59.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":[{"start":74,"end":81,"probability":0.5913,"type":"Person","normalized_text":"Clinuvel"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"363092719112949761"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"RT @WHO: From Sept 2012 to date, WHO has been informed of a total of 94 lab-confirmed cases of infection w/ #MERS-CoV incl 46 deaths","id":"362970162594861056","created_at":"2013-08-01T16:16:45.000Z","entities":{"urls":{},"hashtags":[{"start":108,"end":113,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362970162594861056","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362969370760183809"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO has been notified of 3 more lab-confirmed cases of Middle-East respiratory syndrome coronavirus infection in Saudi Arabia #MER…","id":"362970149944848384","created_at":"2013-08-01T16:16:42.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":122,"end":133,"probability":0.8997,"type":"Place","normalized_text":"Saudi Arabia"}]},"public_metrics":{"retweet_count":76,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362970149944848384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362968667299905536"}],"attachments":{"media_keys":{}}},{"text":"Our guideline on medicines for the treatment of amyotrophic lateral sclerosis (#ALS) is open for public consultation: http://t.co/w3dPAKnzED","id":"362963486529175552","created_at":"2013-08-01T15:50:13.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/w3dPAKnzED","expanded_url":"http://bit.ly/13DJIeH","display_url":"bit.ly/13DJIeH"}],"hashtags":[{"start":79,"end":83,"tag":"ALS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362963486529175552","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Safety warnings and messages for medicines: Information sent to healthcare professionals in July about the saf... http:/…","id":"362955452143128576","created_at":"2013-08-01T15:18:17.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362955452143128576","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362955338829406208"}],"attachments":{"media_keys":{}}},{"text":"Our concept paper on development of product-specific guidance on #bioequivalence is open for consultation: http://t.co/eISk9bSd8U","id":"362950721869590528","created_at":"2013-08-01T14:59:30.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":65,"end":80,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"362950721869590528","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We're introducing digital signatures for some documents next month: http://t.co/MD4au6ypdA","id":"362929366818234369","created_at":"2013-08-01T13:34:38.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/MD4au6ypdA","expanded_url":"http://bit.ly/15ftKO7","display_url":"bit.ly/15ftKO7"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362929366818234369","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We're running a consultation on a novel model of disease progression &amp; trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","id":"362910722495225857","created_at":"2013-08-01T12:20:33.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":95,"end":105,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362910722495225857","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'Engineered mice act as hepatitis C model' - http://t.co/w9vn87aFoW","id":"362901405486841856","created_at":"2013-08-01T11:43:32.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/w9vn87aFoW","expanded_url":"http://bit.ly/13AcAUW","display_url":"bit.ly/13AcAUW"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362901405486841856","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362901300742066176"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: Functional differences between aggregated and dispersed insulin-producing cells - http://t.co/nWOZL3rziy","id":"362899422180827136","created_at":"2013-08-01T11:35:39.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/nWOZL3rziy","expanded_url":"http://goo.gl/pfrmr1","display_url":"goo.gl/pfrmr1"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362899422180827136","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362899333324091392"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: EC Decision C(2013)4967 for medicinal products containing \"cyproterone acetate/ethinylestradiol (2mg/0.035mg)\" http://t.co/318…","id":"362898633920118784","created_at":"2013-08-01T11:32:31.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362898633920118784","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362898584787619841"}],"attachments":{"media_keys":{}}},{"text":"We've just released an update on the reshaping of our organisation: http://t.co/Gi1YpaqP8b","id":"362891760558546944","created_at":"2013-08-01T11:05:12.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/Gi1YpaqP8b","expanded_url":"http://bit.ly/16lLHsY","display_url":"bit.ly/16lLHsY"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362891760558546944","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Decision of @EU_Commission to set up expert group on #rarediseases adopted. Call for expression of interest to follow http:/…","id":"362885189422575616","created_at":"2013-08-01T10:39:05.000Z","entities":{"urls":{},"hashtags":[{"start":68,"end":81,"tag":"rarediseases"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":27,"end":41,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362885189422575616","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362885109168357376"}],"attachments":{"media_keys":{}}},{"text":"RT @eurordis: Continuing need for expert group on #RareDiseases EUCERD. @EU_Health Commission calls for continuing http://t.co/qVsfoasvX6","id":"362876498296205312","created_at":"2013-08-01T10:04:33.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/qVsfoasvX6","expanded_url":"http://ow.ly/nwFFT","display_url":"ow.ly/nwFFT"}],"hashtags":[{"start":50,"end":63,"tag":"RareDiseases"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":72,"end":82,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362876498296205312","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362862863112601600"}],"attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Limited use of medicines containing codeine in children and some adults http://t.co/enDo2QTKiX","id":"362876408567054336","created_at":"2013-08-01T10:04:12.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/enDo2QTKiX","expanded_url":"http://bit.ly/16Hqaca","display_url":"bit.ly/16Hqaca"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362876408567054336","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: New #antibiotic that attacks MRSA found in ocean microbe http://t.co/WMAGJJBkKM","id":"362862774764199936","created_at":"2013-08-01T09:10:01.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/WMAGJJBkKM","expanded_url":"http://www.bbc.co.uk/news/science-environment-23523507","display_url":"bbc.co.uk/news/science-e…"}],"hashtags":[{"start":25,"end":36,"tag":"antibiotic"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362862774764199936","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362856088200163329"}],"attachments":{"media_keys":{}}},{"text":"RT @eurordis: #OrphanDrug Adoption: the More Regulation, the Better http://t.co/plT0GsIiUc #RareDisease","id":"362850217353576448","created_at":"2013-08-01T08:20:07.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/plT0GsIiUc","expanded_url":"http://ow.ly/nwAFM","display_url":"ow.ly/nwAFM"}],"hashtags":[{"start":14,"end":25,"tag":"OrphanDrug"},{"start":91,"end":103,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362850217353576448","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362848190862606336"}],"attachments":{"media_keys":{}}},{"text":"Find out what we've been up to in the first half of this year: http://t.co/9ZLX9NTkdd","id":"362847135365996545","created_at":"2013-08-01T08:07:53.000Z","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/9ZLX9NTkdd","expanded_url":"http://bit.ly/12FviAL","display_url":"bit.ly/12FviAL"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362847135365996545","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our draft revised guideline on medicines for the treatment of #hypertension is open for public consultation: http://t.co/MmzIIcOQWO","id":"362846697379987457","created_at":"2013-08-01T08:06:08.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/MmzIIcOQWO","expanded_url":"http://bit.ly/13vcKxK","display_url":"bit.ly/13vcKxK"}],"hashtags":[{"start":62,"end":75,"tag":"hypertension"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362846697379987457","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Maci is available on our website: an advanced therapy for the repair of knee #cartilage defects: http://t.co/7mMdwNKSVm","id":"362846528605396992","created_at":"2013-08-01T08:05:28.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/7mMdwNKSVm","expanded_url":"http://bit.ly/13moUww","display_url":"bit.ly/13moUww"}],"hashtags":[{"start":13,"end":18,"tag":"Maci"},{"start":91,"end":101,"tag":"cartilage"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362846528605396992","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Hexacima is available: vaccine against #diphtheria, #tetanus, #pertussis, #hepatitisB, #polio &amp; #Hib: http://t.co/mX4QxSqyHb","id":"362846334203592704","created_at":"2013-08-01T08:04:42.000Z","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/mX4QxSqyHb","expanded_url":"http://bit.ly/1aWqgjk","display_url":"bit.ly/1aWqgjk"}],"hashtags":[{"start":13,"end":22,"tag":"Hexacima"},{"start":53,"end":64,"tag":"diphtheria"},{"start":66,"end":74,"tag":"tetanus"},{"start":76,"end":86,"tag":"pertussis"},{"start":88,"end":99,"tag":"hepatitisB"},{"start":101,"end":107,"tag":"polio"},{"start":114,"end":118,"tag":"Hib"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362846334203592704","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Hexyon is available: vaccine against #diphtheria, #tetanus, #pertussis, #hepatitisB, #polio &amp; #Hib: http://t.co/TzShIooCr3","id":"362846122768736257","created_at":"2013-08-01T08:03:51.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/TzShIooCr3","expanded_url":"http://bit.ly/1eaKLZo","display_url":"bit.ly/1eaKLZo"}],"hashtags":[{"start":13,"end":20,"tag":"Hexyon"},{"start":51,"end":62,"tag":"diphtheria"},{"start":64,"end":72,"tag":"tetanus"},{"start":74,"end":84,"tag":"pertussis"},{"start":86,"end":97,"tag":"hepatitisB"},{"start":99,"end":105,"tag":"polio"},{"start":112,"end":116,"tag":"Hib"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362846122768736257","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We're saying goodbye to our Head of Human Medicines Development and Evaluation, Patrick Le Courtois, after 16 years: http://t.co/3uIG3GlQj3","id":"362845888038703106","created_at":"2013-08-01T08:02:55.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/3uIG3GlQj3","expanded_url":"http://bit.ly/166bMu8","display_url":"bit.ly/166bMu8"}],"hashtags":{},"mentions":{},"annotations":[{"start":80,"end":98,"probability":0.9911,"type":"Person","normalized_text":"Patrick Le Courtois"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362845888038703106","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Antibodies against common target on different influenza viruses suggest strategy for influenza vaccine development http://t.co…","id":"362600601986662400","created_at":"2013-07-31T15:48:14.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362600601986662400","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362600226470637569"}],"attachments":{"media_keys":{}}},{"text":"We've published a round-up of our main activities in the first half of this year: http://t.co/9ZLX9NTkdd","id":"362588125052149760","created_at":"2013-07-31T14:58:40.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/9ZLX9NTkdd","expanded_url":"http://bit.ly/12FviAL","display_url":"bit.ly/12FviAL"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362588125052149760","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've released a draft revised guideline on medicines for the treatment of #hypertension for public consultation: http://t.co/MmzIIcOQWO","id":"362575046469894144","created_at":"2013-07-31T14:06:42.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/MmzIIcOQWO","expanded_url":"http://bit.ly/13vcKxK","display_url":"bit.ly/13vcKxK"}],"hashtags":[{"start":75,"end":88,"tag":"hypertension"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362575046469894144","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: Excellent article from all perspectives re. the EFPIA, PhRMA Joint Principles on access to clinical trial data: http://t.co/…","id":"362565383212896257","created_at":"2013-07-31T13:28:18.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362565383212896257","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362563707986903043"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Further information from the President of the Polish medicines agency relating to Diane 35 medicines http://t.co/8KfK4tQJa5","id":"362565086063230979","created_at":"2013-07-31T13:27:07.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/8KfK4tQJa5","expanded_url":"http://fb.me/29m0D9ISG","display_url":"fb.me/29m0D9ISG"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":95,"end":99,"probability":0.6142,"type":"Person","normalized_text":"Diane"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"362565086063230979","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: The new @IMI_JU partnership aims to find #newdrugs to cure top #diseases identified by @WHO. More in #HorizonMagEU htt…","id":"362557155276103682","created_at":"2013-07-31T12:55:36.000Z","entities":{"urls":{},"hashtags":[{"start":62,"end":71,"tag":"newdrugs"},{"start":84,"end":93,"tag":"diseases"},{"start":122,"end":135,"tag":"HorizonMagEU"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":29,"end":36,"username":"imi_ju","id":"1473203261469790214"},{"start":108,"end":112,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362557155276103682","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362556143530278914"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Fascinating film \"Watching the #brain in action\" http://t.co/9EwTtcfxGO via @euronews","id":"362545545597829120","created_at":"2013-07-31T12:09:28.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/9EwTtcfxGO","expanded_url":"http://www.euronews.com/2013/07/23/watching-the-brain-in-action/","display_url":"euronews.com/2013/07/23/wat…"}],"hashtags":[{"start":47,"end":53,"tag":"brain"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":92,"end":101,"username":"euronews","id":"25067168"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362545545597829120","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362545269008633857"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Maci: an advanced therapy for the repair of knee #cartilage defects: http://t.co/7mMdwNKSVm","id":"362544862303752193","created_at":"2013-07-31T12:06:45.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/7mMdwNKSVm","expanded_url":"http://bit.ly/13moUww","display_url":"bit.ly/13moUww"}],"hashtags":[{"start":42,"end":47,"tag":"Maci"},{"start":92,"end":102,"tag":"cartilage"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362544862303752193","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published #Hexacima's assessment report: #diphtheria, #tetanus, #pertussis, #hepatitisB, #polio &amp; #Hib vaccine: http://t.co/mX4QxSqyHb","id":"362539993496956928","created_at":"2013-07-31T11:47:24.000Z","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/mX4QxSqyHb","expanded_url":"http://bit.ly/1aWqgjk","display_url":"bit.ly/1aWqgjk"}],"hashtags":[{"start":16,"end":25,"tag":"Hexacima"},{"start":47,"end":58,"tag":"diphtheria"},{"start":60,"end":68,"tag":"tetanus"},{"start":70,"end":80,"tag":"pertussis"},{"start":82,"end":93,"tag":"hepatitisB"},{"start":95,"end":101,"tag":"polio"},{"start":108,"end":112,"tag":"Hib"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362539993496956928","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published #Hexyon's assessment report: #diphtheria, #tetanus, #pertussis, #hepatitisB, #polio &amp; #Hib vaccine: http://t.co/TzShIooCr3","id":"362537829433212930","created_at":"2013-07-31T11:38:48.000Z","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/TzShIooCr3","expanded_url":"http://bit.ly/1eaKLZo","display_url":"bit.ly/1eaKLZo"}],"hashtags":[{"start":16,"end":23,"tag":"Hexyon"},{"start":45,"end":56,"tag":"diphtheria"},{"start":58,"end":66,"tag":"tetanus"},{"start":68,"end":78,"tag":"pertussis"},{"start":80,"end":91,"tag":"hepatitisB"},{"start":93,"end":99,"tag":"polio"},{"start":106,"end":110,"tag":"Hib"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362537829433212930","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our guideline on using starting materials and intermediates from different sources for #biologicals is available: http://t.co/QphlXLE5el","id":"362529552624386051","created_at":"2013-07-31T11:05:55.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/QphlXLE5el","expanded_url":"http://bit.ly/18Rdqpp","display_url":"bit.ly/18Rdqpp"}],"hashtags":[{"start":87,"end":99,"tag":"biologicals"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362529552624386051","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Iclusig (#ponatinib) for the treatment of #leukaemia is available on our website: http://t.co/MLSZ0zYUFg","id":"362529430461100032","created_at":"2013-07-31T11:05:26.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/MLSZ0zYUFg","expanded_url":"http://bit.ly/17hps4s","display_url":"bit.ly/17hps4s"}],"hashtags":[{"start":13,"end":21,"tag":"Iclusig"},{"start":23,"end":33,"tag":"ponatinib"},{"start":56,"end":66,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362529430461100032","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our #fees are changing as of 4 August: http://t.co/s24SCLEBR7","id":"362529262684737537","created_at":"2013-07-31T11:04:46.000Z","entities":{"urls":[{"start":39,"end":61,"url":"http://t.co/s24SCLEBR7","expanded_url":"http://bit.ly/13m3GPE","display_url":"bit.ly/13m3GPE"}],"hashtags":[{"start":4,"end":9,"tag":"fees"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362529262684737537","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our Head of Human Medicines Development and Evaluation, Patrick Le Courtois, is retiring after 16 years of service: http://t.co/3uIG3GlQj3","id":"362528740141572096","created_at":"2013-07-31T11:02:41.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/3uIG3GlQj3","expanded_url":"http://bit.ly/166bMu8","display_url":"bit.ly/166bMu8"}],"hashtags":{},"mentions":{},"annotations":[{"start":56,"end":74,"probability":0.9886,"type":"Person","normalized_text":"Patrick Le Courtois"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362528740141572096","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Viral Hepatitis described as the 'Other Killer' in this interesting article comparing it with HIV/AIDS http://t.co/jrh0Vm…","id":"362524590708240384","created_at":"2013-07-31T10:46:12.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362524590708240384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362524457413263360"}],"attachments":{"media_keys":{}}},{"text":"RT @ESEndocrinology: Our journal EJE in the news: a smart way of delivering #testosterone http://t.co/09UYsAl6A7","id":"362523223679700992","created_at":"2013-07-31T10:40:46.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/09UYsAl6A7","expanded_url":"http://bit.ly/18KLT5g","display_url":"bit.ly/18KLT5g"}],"hashtags":[{"start":76,"end":89,"tag":"testosterone"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362523223679700992","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362517714499149825"}],"attachments":{"media_keys":{}}},{"text":"We've published a guideline on using starting materials and intermediates from different sources for biologicals: http://t.co/QphlXLE5el","id":"362518252104073216","created_at":"2013-07-31T10:21:01.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/QphlXLE5el","expanded_url":"http://bit.ly/18Rdqpp","display_url":"bit.ly/18Rdqpp"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"362518252104073216","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRApress: Arrests made in unlicensed sex drugs raids http://t.co/0UxhDYvO2S","id":"362515584992292864","created_at":"2013-07-31T10:10:25.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/0UxhDYvO2S","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON297563","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362515584992292864","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362515414883905537"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: ESMOChannel: Oxaliplatin-induced sensory #neurotoxicity: still an unmet medical need - A. Sobrero http://t.co/viKokPLwhw","id":"362513943127797761","created_at":"2013-07-31T10:03:53.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/viKokPLwhw","expanded_url":"http://bit.ly/15v2rwS","display_url":"bit.ly/15v2rwS"}],"hashtags":[{"start":53,"end":67,"tag":"neurotoxicity"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":99,"end":108,"probability":0.5262,"type":"Person","normalized_text":"A. Sobrero"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362513943127797761","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362513712201994240"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: #diabetes - Molecular mechanism of action of metformin: old or new insights? - http://t.co/O1fF1n9XWR","id":"362512090726006786","created_at":"2013-07-31T09:56:32.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/O1fF1n9XWR","expanded_url":"http://goo.gl/cXRw8H","display_url":"goo.gl/cXRw8H"}],"hashtags":[{"start":14,"end":23,"tag":"diabetes"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362512090726006786","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362511698709577732"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Iclusig (#ponatinib) for the treatment of #leukaemia: http://t.co/MLSZ0zYUFg","id":"362511494140801024","created_at":"2013-07-31T09:54:10.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/MLSZ0zYUFg","expanded_url":"http://bit.ly/17hps4s","display_url":"bit.ly/17hps4s"}],"hashtags":[{"start":42,"end":50,"tag":"Iclusig"},{"start":52,"end":62,"tag":"ponatinib"},{"start":85,"end":95,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362511494140801024","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: The biology of FTO: from nucleic acid demethylase to amino acid sensor - http://t.co/NuMPJMyZzt","id":"362510847081316352","created_at":"2013-07-31T09:51:35.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/NuMPJMyZzt","expanded_url":"http://goo.gl/UUM2IB","display_url":"goo.gl/UUM2IB"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362510847081316352","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362510672929619969"}],"attachments":{"media_keys":{}}},{"text":"We provided advice on use of #colistin and #tigecycline in animals: http://t.co/RZM6AGuYa6","id":"362507060048441345","created_at":"2013-07-31T09:36:32.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/RZM6AGuYa6","expanded_url":"http://bit.ly/16ynk9j","display_url":"bit.ly/16ynk9j"}],"hashtags":[{"start":29,"end":38,"tag":"colistin"},{"start":43,"end":55,"tag":"tigecycline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362507060048441345","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Breast #Cancer risk can be predicted using new technique http://t.co/0h51GJrbyI","id":"362501930704052224","created_at":"2013-07-31T09:16:09.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/0h51GJrbyI","expanded_url":"http://bit.ly/12DaeLh","display_url":"bit.ly/12DaeLh"}],"hashtags":[{"start":18,"end":25,"tag":"Cancer"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362501930704052224","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362501743428378625"}],"attachments":{"media_keys":{}}},{"text":"Our revised rules on #fees are coming into effect on 4 August: http://t.co/s24SCLEBR7","id":"362498515496222720","created_at":"2013-07-31T09:02:35.000Z","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/s24SCLEBR7","expanded_url":"http://bit.ly/13m3GPE","display_url":"bit.ly/13m3GPE"}],"hashtags":[{"start":21,"end":26,"tag":"fees"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362498515496222720","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Imatinib Accord, a #generic of #Glivec for the treatment of cancer is available on our website: http://t.co/lngLd8893w","id":"362495957734141952","created_at":"2013-07-31T08:52:25.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/lngLd8893w","expanded_url":"http://bit.ly/18Pljvf","display_url":"bit.ly/18Pljvf"}],"hashtags":[{"start":13,"end":22,"tag":"Imatinib"},{"start":33,"end":41,"tag":"generic"},{"start":45,"end":52,"tag":"Glivec"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362495957734141952","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The EPAR for #Erivedge (#vismodegib) for adults with #basalcellcarcinoma is available on our website: http://t.co/P4kRAMZfkb","id":"362495854893993984","created_at":"2013-07-31T08:52:01.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/P4kRAMZfkb","expanded_url":"http://bit.ly/14xkuyy","display_url":"bit.ly/14xkuyy"}],"hashtags":[{"start":13,"end":22,"tag":"Erivedge"},{"start":24,"end":35,"tag":"vismodegib"},{"start":53,"end":72,"tag":"basalcellcarcinoma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362495854893993984","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Earlier this week was World #Hepatitis Day - want to find out more about the disease? Check Efpia website http://t.co/jmIOKsXDwQ","id":"362491821152149504","created_at":"2013-07-31T08:35:59.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/jmIOKsXDwQ","expanded_url":"http://bit.ly/162lzBn","display_url":"bit.ly/162lzBn"}],"hashtags":[{"start":39,"end":49,"tag":"Hepatitis"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362491821152149504","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362484529727934464"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Imatinib Accord, a #generic of #Glivec for the treatment of cancer: http://t.co/lngLd8893w","id":"362241787252842498","created_at":"2013-07-30T16:02:26.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/lngLd8893w","expanded_url":"http://bit.ly/18Pljvf","display_url":"bit.ly/18Pljvf"}],"hashtags":[{"start":42,"end":51,"tag":"Imatinib"},{"start":62,"end":70,"tag":"generic"},{"start":74,"end":81,"tag":"Glivec"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"362241787252842498","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We’ve published the EPAR for #Capecitabine SUN: #generic of #Xeloda for treating various types of #cancer: http://t.co/26YHYG7NND","id":"362182376937365504","created_at":"2013-07-30T12:06:22.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/26YHYG7NND","expanded_url":"http://bit.ly/11dzqFb","display_url":"bit.ly/11dzqFb"}],"hashtags":[{"start":29,"end":42,"tag":"Capecitabine"},{"start":48,"end":56,"tag":"generic"},{"start":60,"end":67,"tag":"Xeloda"},{"start":98,"end":105,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362182376937365504","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EUombudsman: The Ombudsman very much welcomes @ema_news'  positive response to his draft recommendation http://t.co/itR9sfdUmd","id":"362180923237736448","created_at":"2013-07-30T12:00:35.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/itR9sfdUmd","expanded_url":"http://bit.ly/13W4lH4","display_url":"bit.ly/13W4lH4"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":50,"end":59,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":21,"end":29,"probability":0.3834,"type":"Organization","normalized_text":"Ombudsman"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362180923237736448","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"362180687836622848"}],"attachments":{"media_keys":{}}},{"text":"@wombarrapete We're sorry but we cannot give you this information as it relates to an ongoing evaluation.","id":"362174543122538496","created_at":"2013-07-30T11:35:14.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362174073574408193"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"@wombarrapete We can't release specific details on any ongoing evaluations. We will publish more as soon as the CHMP reaches its opinion.","id":"362172592511139840","created_at":"2013-07-30T11:27:29.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362170744597266434"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"We provide advice on use of #colistin and #tigecycline in animals: http://t.co/RZM6AGuYa6","id":"362168919961772032","created_at":"2013-07-30T11:12:53.000Z","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/RZM6AGuYa6","expanded_url":"http://bit.ly/16ynk9j","display_url":"bit.ly/16ynk9j"}],"hashtags":[{"start":28,"end":37,"tag":"colistin"},{"start":42,"end":54,"tag":"tigecycline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362168919961772032","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@wombarrapete The clock stop is the time that the applicant company has to respond to our questions on the medicine being evaluated.","id":"362168827154399232","created_at":"2013-07-30T11:12:31.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362168665245892608"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"@wombarrapete The longest in the link we supplied was NexoBrid - 210 active days + 463 clock stop = 673 days or about 22 months.","id":"362168665245892608","created_at":"2013-07-30T11:11:53.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362167070118526976"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"We've published the assessment report for #Erivedge (#vismodegib) for adults with #basalcellcarcinoma: http://t.co/P4kRAMZfkb","id":"362165563251888128","created_at":"2013-07-30T10:59:33.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/P4kRAMZfkb","expanded_url":"http://bit.ly/14xkuyy","display_url":"bit.ly/14xkuyy"}],"hashtags":[{"start":42,"end":51,"tag":"Erivedge"},{"start":53,"end":64,"tag":"vismodegib"},{"start":82,"end":101,"tag":"basalcellcarcinoma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"362165563251888128","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@wombarrapete The evaluation of medicines' benefits and risks is complex and takes many months. See annex 9 for 2012: http://t.co/nPV88F2JUI","id":"362163235622879232","created_at":"2013-07-30T10:50:18.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/nPV88F2JUI","expanded_url":"http://bit.ly/1e7Yd0b","display_url":"bit.ly/1e7Yd0b"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362155440265625600"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"@louis_ide Full details on our review are here: http://t.co/nQwHuqrpnr","id":"362134424428609536","created_at":"2013-07-30T08:55:49.000Z","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/nQwHuqrpnr","expanded_url":"http://bit.ly/19ulYBT","display_url":"bit.ly/19ulYBT"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360690347334057984","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"362133960878342145"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1548804618"},{"text":"@wombarrapete We are still evaluating the benefits and risks of Scenesse. We will issue a recommendation as soon as this is complete.","id":"362133052643749888","created_at":"2013-07-30T08:50:22.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":[{"start":64,"end":71,"probability":0.2649,"type":"Organization","normalized_text":"Scenesse"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"361241702264082432"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17509073"},{"text":"@louis_ide We expect to issue a recommendation on domperidone in December at the earliest: http://t.co/fbKo4AMP7U","id":"362132260981440512","created_at":"2013-07-30T08:47:13.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":2,"like_count":1,"quote_count":0},"conversation_id":"360690347334057984","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"360700049375772672"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1548804618"},{"text":"One more week to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"361836812014075907","created_at":"2013-07-29T13:13:13.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"361836812014075907","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on our draft #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"361836626688737281","created_at":"2013-07-29T13:12:29.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"361836626688737281","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our finalised guideline on requirements for combined #vaccines and associations of IVMPs is now available: http://t.co/jjRl5WqmSv","id":"361835838235086848","created_at":"2013-07-29T13:09:21.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/jjRl5WqmSv","expanded_url":"http://bit.ly/1c675GV","display_url":"bit.ly/1c675GV"}],"hashtags":[{"start":53,"end":62,"tag":"vaccines"}],"mentions":{},"annotations":[{"start":83,"end":87,"probability":0.3448,"type":"Organization","normalized_text":"IVMPs"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"361835838235086848","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"361800660603248640","created_at":"2013-07-29T10:49:34.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"361800660603248640","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our draft #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"361800547289939968","created_at":"2013-07-29T10:49:07.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"361800547289939968","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/iNybk9S0Vd","id":"361780825404084224","created_at":"2013-07-29T09:30:44.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/iNybk9S0Vd","expanded_url":"http://bit.ly/15PIQqa","display_url":"bit.ly/15PIQqa"}],"hashtags":[{"start":20,"end":24,"tag":"GLP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"361780825404084224","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommend changes to the use of #metoclopramide: http://t.co/mBUtjSDI6S","id":"361780644134658048","created_at":"2013-07-29T09:30:01.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/mBUtjSDI6S","expanded_url":"http://bit.ly/1dZrdXF","display_url":"bit.ly/1dZrdXF"}],"hashtags":[{"start":35,"end":50,"tag":"metoclopramide"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"361780644134658048","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/qdFoA4IN6O","id":"361780557295783937","created_at":"2013-07-29T09:29:41.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/qdFoA4IN6O","expanded_url":"http://bit.ly/13gJEkI","display_url":"bit.ly/13gJEkI"}],"hashtags":[{"start":61,"end":74,"tag":"ketoconazole"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"361780557295783937","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We published the CHMP meeting highlights on Friday: http://t.co/0yt85BB8Ef","id":"361780390639312896","created_at":"2013-07-29T09:29:01.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/0yt85BB8Ef","expanded_url":"http://bit.ly/1bUzNuf","display_url":"bit.ly/1bUzNuf"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"361780390639312896","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We support World #Hepatitis Day which is taking place the 28th July 2013: http://t.co/rTKCgXL8Ds","id":"360804806153089024","created_at":"2013-07-26T16:52:23.000Z","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/rTKCgXL8Ds","expanded_url":"http://bit.ly/11jvHWt","display_url":"bit.ly/11jvHWt"}],"hashtags":[{"start":17,"end":27,"tag":"Hepatitis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360804806153089024","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've just published the 2012 annual report on EudraVigilance: http://t.co/WNKeThEau6","id":"360776962278559744","created_at":"2013-07-26T15:01:45.000Z","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/WNKeThEau6","expanded_url":"http://bit.ly/1bVeXem","display_url":"bit.ly/1bVeXem"}],"hashtags":{},"mentions":{},"annotations":[{"start":47,"end":60,"probability":0.3312,"type":"Organization","normalized_text":"EudraVigilance"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360776962278559744","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've just published the CHMP meeting highlights: http://t.co/0yt85BB8Ef","id":"360726350052605952","created_at":"2013-07-26T11:40:38.000Z","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/0yt85BB8Ef","expanded_url":"http://bit.ly/1bUzNuf","display_url":"bit.ly/1bUzNuf"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360726350052605952","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommend changes to the use of #metoclopramide: http://t.co/mBUtjSDI6S","id":"360690347334057984","created_at":"2013-07-26T09:17:34.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/mBUtjSDI6S","expanded_url":"http://bit.ly/1dZrdXF","display_url":"bit.ly/1dZrdXF"}],"hashtags":[{"start":35,"end":50,"tag":"metoclopramide"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":4,"like_count":2,"quote_count":0},"conversation_id":"360690347334057984","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/qdFoA4IN6O","id":"360690076939862016","created_at":"2013-07-26T09:16:30.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/qdFoA4IN6O","expanded_url":"http://bit.ly/13gJEkI","display_url":"bit.ly/13gJEkI"}],"hashtags":[{"start":61,"end":74,"tag":"ketoconazole"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"360690076939862016","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/iNybk9S0Vd","id":"360689641986338816","created_at":"2013-07-26T09:14:46.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/iNybk9S0Vd","expanded_url":"http://bit.ly/15PIQqa","display_url":"bit.ly/15PIQqa"}],"hashtags":[{"start":20,"end":24,"tag":"GLP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"360689641986338816","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Regulatory information - Revision of procedural guidance to reflect update of variations guidelines from the EC:\n http://t.co/9f4njgaBmc","id":"360351426402189313","created_at":"2013-07-25T10:50:49.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/9f4njgaBmc","expanded_url":"http://bit.ly/171EUBP","display_url":"bit.ly/171EUBP"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"360351426402189313","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EPHA_EU: #UK's Goverment (@GOVUK) review of balance of competences between United Kingdom &amp; #EU on #Health: http://t.co/myeQNttuuT  #UK…","id":"360030038235688960","created_at":"2013-07-24T13:33:44.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/myeQNttuuT","expanded_url":"http://bit.ly/12INILA","display_url":"bit.ly/12INILA"}],"hashtags":[{"start":13,"end":16,"tag":"UK"},{"start":100,"end":103,"tag":"EU"},{"start":107,"end":114,"tag":"Health"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":30,"end":36,"username":"GOVUK","id":"17481977"}],"annotations":[{"start":79,"end":92,"probability":0.554,"type":"Place","normalized_text":"United Kingdom"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360030038235688960","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"360023548946948097"}],"attachments":{"media_keys":{}}},{"text":"The assessment report for #Capecitabine SUN is available: #generic of #Xeloda for treating various types of #cancer: http://t.co/26YHYG7NND","id":"360020153976635392","created_at":"2013-07-24T12:54:28.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/26YHYG7NND","expanded_url":"http://bit.ly/11dzqFb","display_url":"bit.ly/11dzqFb"}],"hashtags":[{"start":26,"end":39,"tag":"Capecitabine"},{"start":58,"end":66,"tag":"generic"},{"start":70,"end":77,"tag":"Xeloda"},{"start":108,"end":115,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"360020153976635392","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Spedra (#avanfil) for #erectile #dysfunction: http://t.co/rsED8P2sFH","id":"359998819011788800","created_at":"2013-07-24T11:29:41.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/rsED8P2sFH","expanded_url":"http://bit.ly/16YMCMX","display_url":"bit.ly/16YMCMX"}],"hashtags":[{"start":29,"end":36,"tag":"Spedra"},{"start":38,"end":46,"tag":"avanfil"},{"start":52,"end":61,"tag":"erectile"},{"start":62,"end":74,"tag":"dysfunction"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359998819011788800","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: @WHO webinar has just begun for release of new Viral Hepatitis Global Report for #WorldHepDay 2013 sign up here http://t.…","id":"359998097130127362","created_at":"2013-07-24T11:26:49.000Z","entities":{"urls":{},"hashtags":[{"start":99,"end":111,"tag":"WorldHepDay"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":18,"end":22,"username":"WHO","id":"14499829"}],"annotations":[{"start":65,"end":93,"probability":0.4011,"type":"Other","normalized_text":"Viral Hepatitis Global Report"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359998097130127362","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359985451106451456"}],"attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: IMI’s lunchtime symposium  @EACPT  on 29/8 showcases our cross-project platforms’ innovation through collaboration http://t.co/…","id":"359997660951887872","created_at":"2013-07-24T11:25:05.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":39,"end":45,"username":"EACPT","id":"234897146"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359997660951887872","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359974820357746688"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: EFPIA Director General Richard Bergstrom blogs on today's news re. EFPIA PhRMA Joint Commitment to Data Sharing - http://t.co/tR…","id":"359969402675933184","created_at":"2013-07-24T09:32:48.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":34,"end":50,"probability":0.5848,"type":"Person","normalized_text":"Richard Bergstrom"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359969402675933184","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359969059141464067"}],"attachments":{"media_keys":{}}},{"text":"@HJF29088181 We've fixed the problem with this PIP now. Apologies for the inconvenience.","id":"359957013029064704","created_at":"2013-07-24T08:43:34.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"359923356054732800","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"359923356054732800"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"RT @WHO: Viral hepatitis is a group of infectious diseases that affects hundreds of millions of people worldwide http://t.co/kaSBy8oH3i #Wo…","id":"359956593485426688","created_at":"2013-07-24T08:41:54.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/kaSBy8oH3i","expanded_url":"http://goo.gl/C7vyG2","display_url":"goo.gl/C7vyG2"}],"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359956593485426688","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359956534408642561"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: On World Hepatitis Day, 28 July, WHO is urging gov'ts to act against 5 hepatitis viruses that can cause severe liver infections #W…","id":"359956534261846016","created_at":"2013-07-24T08:41:40.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":109,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359956534261846016","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359956211979919363"}],"attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Stayveer (#bosentan) for pulmonary arterial #hypertension: http://t.co/vrzWB5CzJ7","id":"359953990714277889","created_at":"2013-07-24T08:31:33.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/vrzWB5CzJ7","expanded_url":"http://bit.ly/15dFrlQ","display_url":"bit.ly/15dFrlQ"}],"hashtags":[{"start":29,"end":38,"tag":"Stayveer"},{"start":40,"end":49,"tag":"bosentan"},{"start":74,"end":87,"tag":"hypertension"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359953990714277889","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The assessment report for #Spedra (#avanfil) for #erectile #dysfunction is available on our website: http://t.co/rsED8P2sFH","id":"359953672479846401","created_at":"2013-07-24T08:30:17.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/rsED8P2sFH","expanded_url":"http://bit.ly/16YMCMX","display_url":"bit.ly/16YMCMX"}],"hashtags":[{"start":26,"end":33,"tag":"Spedra"},{"start":35,"end":43,"tag":"avanfil"},{"start":49,"end":58,"tag":"erectile"},{"start":59,"end":71,"tag":"dysfunction"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359953672479846401","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The assessment report for #Stayveer (#bosentan) is available on our website: for pulmonary arterial hypertension: http://t.co/vrzWB5CzJ7","id":"359711818026991616","created_at":"2013-07-23T16:29:15.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/vrzWB5CzJ7","expanded_url":"http://bit.ly/15dFrlQ","display_url":"bit.ly/15dFrlQ"}],"hashtags":[{"start":26,"end":35,"tag":"Stayveer"},{"start":37,"end":46,"tag":"bosentan"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359711818026991616","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Viral #hepatitis, its treatment &amp; needs of people living with it in Europe: check @infohep website http://t.co/RhYobAY7jm #W…","id":"359698613078728705","created_at":"2013-07-23T15:36:46.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/RhYobAY7jm","expanded_url":"http://www.infohep.org","display_url":"infohep.org"}],"hashtags":[{"start":21,"end":31,"tag":"hepatitis"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":101,"end":109,"username":"infohep","id":"962681528"}],"annotations":[{"start":83,"end":88,"probability":0.9927,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359698613078728705","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359695813397594113"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAMedWatch: Diabetes Treatments: FDA Alerts of Illegal Sales - Undeclared Ingredients http://t.co/JhbDJRSVki #FDA","id":"359693474800480257","created_at":"2013-07-23T15:16:21.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/JhbDJRSVki","expanded_url":"http://go.usa.gov/jKwx","display_url":"go.usa.gov/jKwx"}],"hashtags":[{"start":114,"end":118,"tag":"FDA"}],"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359693474800480257","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359692067166879744"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: ESMOChannel: How #PersonalisedMedicine will affect #lungcancer patients http://t.co/R1tol5hHLj","id":"359687691660570625","created_at":"2013-07-23T14:53:23.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/R1tol5hHLj","expanded_url":"http://ow.ly/neMVv","display_url":"ow.ly/neMVv"}],"hashtags":[{"start":29,"end":50,"tag":"PersonalisedMedicine"},{"start":63,"end":74,"tag":"lungcancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359687691660570625","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359687531601739779"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA alerts companies to stop illegal sale of treatments for diabetes http://t.co/jlUL4RiCF5","id":"359683151871741953","created_at":"2013-07-23T14:35:20.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/jlUL4RiCF5","expanded_url":"http://1.usa.gov/14CXlRl","display_url":"1.usa.gov/14CXlRl"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8313,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359683151871741953","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359682645183045632"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA alerts companies to stop illegal sale of treatments for #diabetes: http://t.co/MHADTmAzDD.","id":"359682976444989440","created_at":"2013-07-23T14:34:38.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/MHADTmAzDD","expanded_url":"http://1.usa.gov/164rNAt","display_url":"1.usa.gov/164rNAt"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":80,"end":89,"tag":"diabetes"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359682976444989440","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359680875908169728"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: #FDA launches initiative to counter illegally sold #diabetes products. Learn more at http://t.co/1ezShXsGIh","id":"359682946094993409","created_at":"2013-07-23T14:34:31.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/1ezShXsGIh","expanded_url":"http://go.usa.gov/jKPd","display_url":"go.usa.gov/jKPd"}],"hashtags":[{"start":12,"end":16,"tag":"FDA"},{"start":63,"end":72,"tag":"diabetes"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359682946094993409","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359679211679657984"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: #Environmental Impact Considerations from CVM http://t.co/97AXamEhf5","id":"359682930525732867","created_at":"2013-07-23T14:34:27.000Z","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/97AXamEhf5","expanded_url":"http://bit.ly/e3sY8U","display_url":"bit.ly/e3sY8U"}],"hashtags":[{"start":21,"end":35,"tag":"Environmental"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359682930525732867","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359678668076883968"}],"attachments":{"media_keys":{}}},{"text":"RT @ICH_news: ICH celebrates a refreshed and revitalised new visual identity for MedDRA! Visit the new website: http://t.co/5HjCQAr21t","id":"359642569178755072","created_at":"2013-07-23T11:54:04.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/5HjCQAr21t","expanded_url":"http://www.meddra.org/","display_url":"meddra.org"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":[{"start":81,"end":86,"probability":0.3078,"type":"Organization","normalized_text":"MedDRA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359642569178755072","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359642285660569600"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'Searching for Meaningful Markers of Aging' - http://t.co/vTu4s1mzS8","id":"359628918451478529","created_at":"2013-07-23T10:59:50.000Z","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/vTu4s1mzS8","expanded_url":"http://nyti.ms/1aFUQO6","display_url":"nyti.ms/1aFUQO6"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359628918451478529","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359603232848351233"}],"attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: Did you know? The average spend on defensive R&amp;D in Europe for #veterinarymedicine is 35%, double that of the US! http://t.…","id":"359587635779469312","created_at":"2013-07-23T08:15:47.000Z","entities":{"urls":{},"hashtags":[{"start":83,"end":102,"tag":"veterinarymedicine"}],"mentions":{},"annotations":[{"start":68,"end":73,"probability":0.9724,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359587635779469312","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359585339234463744"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe_VPI: Caucasian countries take steps to end #measles outbreaks and help reach 2015 elimination target for European Region htt…","id":"359349488924000256","created_at":"2013-07-22T16:29:29.000Z","entities":{"urls":{},"hashtags":[{"start":58,"end":66,"tag":"measles"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359349488924000256","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359346299130232833"}],"attachments":{"media_keys":{}}},{"text":"RT @CDCgov: Viral hepatitis is a major global health threat. Learn more for #WorldHepDay by visiting: http://t.co/CZ4N8a5SW1.","id":"359349355884863488","created_at":"2013-07-22T16:28:57.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/CZ4N8a5SW1","expanded_url":"http://go.usa.gov/jB8e","display_url":"go.usa.gov/jB8e"}],"hashtags":[{"start":76,"end":88,"tag":"WorldHepDay"}],"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"annotations":{}},"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359349355884863488","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359343665749041152"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'Big leap' towards curing blindness in stem cell study' - http://t.co/O8MAJwI6D2","id":"359324937246748672","created_at":"2013-07-22T14:51:55.000Z","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/O8MAJwI6D2","expanded_url":"http://bbc.in/12Genc3","display_url":"bbc.in/12Genc3"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359324937246748672","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359324731553480706"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Noncommunicable diseases kill more people than infectious diseases, two-thirds of all #deaths globally in 2011 http://t.co/7dZKPkB…","id":"359312935447195648","created_at":"2013-07-22T14:04:14.000Z","entities":{"urls":{},"hashtags":[{"start":95,"end":102,"tag":"deaths"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":146,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359312935447195648","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359312317382529024"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: #Prematurity claimed 200,000 less #infant lives in 2011 than in 2000, but remains among top 10 causes of death http://t.co/C5cx5EB…","id":"359312898793152512","created_at":"2013-07-22T14:04:05.000Z","entities":{"urls":{},"hashtags":[{"start":9,"end":21,"tag":"Prematurity"},{"start":43,"end":50,"tag":"infant"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359312898793152512","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359310202085982210"}],"attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: IMI 9th Call – Q&amp;As now online at http://t.co/dZvYhbsiRm Got more questions? E-mail us – http://t.co/eShHnPEjX1","id":"359308880507318272","created_at":"2013-07-22T13:48:07.000Z","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/dZvYhbsiRm","expanded_url":"http://bit.ly/13SC7bR","display_url":"bit.ly/13SC7bR"},{"start":105,"end":127,"url":"http://t.co/eShHnPEjX1","expanded_url":"http://infodeskATimi.europa.eu","display_url":"infodeskATimi.europa.eu"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359308880507318272","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359308736948486146"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Cardio diseases, lower respiratory infections, chronic obstructive lung disease, diarrhoea, AIDS still top #killers http://t.co/C5…","id":"359307284767596544","created_at":"2013-07-22T13:41:46.000Z","entities":{"urls":{},"hashtags":[{"start":116,"end":124,"tag":"killers"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":105,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359307284767596544","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359307240420806656"}],"attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: IAPO member the European Aids Treatment Group release statement on @guardian article on pharma memo: http://t.co/I7vQvJzyiP…","id":"359307090533576704","created_at":"2013-07-22T13:41:00.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/I7vQvJzyiP","expanded_url":"http://bit.ly/15Zmogm","display_url":"bit.ly/15Zmogm"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":83,"end":92,"username":"guardian","id":"87818409"}],"annotations":[{"start":32,"end":60,"probability":0.35,"type":"Organization","normalized_text":"European Aids Treatment Group"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359307090533576704","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359306932156248064"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Chronic diseases - diabetes, ischaemic heart disease, lung cancers, stroke - cause more and more #deaths worldwide http://t.co/C5c…","id":"359306604153700352","created_at":"2013-07-22T13:39:04.000Z","entities":{"urls":{},"hashtags":[{"start":106,"end":113,"tag":"deaths"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":123,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359306604153700352","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359306356483817473"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: The 2013 update of Primary Cutaneous #Lymphomas (#PCL) ESMO Clinical Practice Guideline is now out! http://t.co/gf5bWrIDSO","id":"359306051075997697","created_at":"2013-07-22T13:36:52.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/gf5bWrIDSO","expanded_url":"http://ow.ly/nc1E5","display_url":"ow.ly/nc1E5"}],"hashtags":[{"start":49,"end":59,"tag":"Lymphomas"},{"start":61,"end":65,"tag":"PCL"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359306051075997697","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359299830641721345"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: As of 18 July 2013, 88 confirmed cases of #MERS-CoV reported worldwide; see latest update: http://t.co/S7tEQ0SGL0","id":"359304466929315840","created_at":"2013-07-22T13:30:35.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/S7tEQ0SGL0","expanded_url":"http://bit.ly/15b32Uh","display_url":"bit.ly/15b32Uh"}],"hashtags":[{"start":55,"end":60,"tag":"MERS"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359304466929315840","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359299821410066432"}],"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: This Weds 24th July WHO will release global report on viral hepatitis prevention and control Sign up to the webinar http:…","id":"359290385262477312","created_at":"2013-07-22T12:34:37.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359290385262477312","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359290306346225665"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: 'MS research could help repair damage affecting nerves' - http://t.co/axv3A1JPTp","id":"359285360121368576","created_at":"2013-07-22T12:14:39.000Z","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/axv3A1JPTp","expanded_url":"http://bit.ly/1aDH9z2","display_url":"bit.ly/1aDH9z2"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359285360121368576","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359281090017497088"}],"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"359266843216711681","created_at":"2013-07-22T11:01:04.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359266843216711681","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our draft #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"359266762228899842","created_at":"2013-07-22T11:00:45.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359266762228899842","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"PRAC: one year of public health promotion and protection: http://t.co/80foENOv00","id":"359243815544041472","created_at":"2013-07-22T09:29:34.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/80foENOv00","expanded_url":"http://bit.ly/14mS686","display_url":"bit.ly/14mS686"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359243815544041472","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: First West Nile fever case of 2013 in the EU/EEA found in Attiki, Greece http://t.co/oA7yR9s1G3; see maps: http://t.co/q6kIyfN…","id":"359242708998967296","created_at":"2013-07-22T09:25:10.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/oA7yR9s1G3","expanded_url":"http://bit.ly/13RCOSH","display_url":"bit.ly/13RCOSH"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":71,"end":84,"probability":0.598,"type":"Place","normalized_text":"Attiki, Greece"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359242708998967296","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359242373622018048"}],"attachments":{"media_keys":{}}},{"text":"On Friday we published the highlights from our #veterinary committee; two new #medicines recommended for #dogs: http://t.co/tHrmvzgmnY","id":"359225848450134016","created_at":"2013-07-22T08:18:11.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/tHrmvzgmnY","expanded_url":"http://bit.ly/12BrECr","display_url":"bit.ly/12BrECr"}],"hashtags":[{"start":47,"end":58,"tag":"veterinary"},{"start":78,"end":88,"tag":"medicines"},{"start":105,"end":110,"tag":"dogs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359225848450134016","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"On Friday we published the agenda for our workshop on conflicts of interests on 6 September: http://t.co/1jnoE1gOSL","id":"359225633026478080","created_at":"2013-07-22T08:17:19.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/1jnoE1gOSL","expanded_url":"http://bit.ly/18sxkqp","display_url":"bit.ly/18sxkqp"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"359225633026478080","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EURLex: New method of #feed #analysis; control of #pesticides residues &amp; #GMO in/on feed of plant and #animal origin http://t.co/LK83IO…","id":"359224611222724608","created_at":"2013-07-22T08:13:16.000Z","entities":{"urls":{},"hashtags":[{"start":26,"end":31,"tag":"feed"},{"start":32,"end":41,"tag":"analysis"},{"start":54,"end":65,"tag":"pesticides"},{"start":81,"end":85,"tag":"GMO"},{"start":110,"end":117,"tag":"animal"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359224611222724608","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"359223311156248577"}],"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","id":"359224104353660931","created_at":"2013-07-22T08:11:15.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"359224104353660931","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our draft #pharmacovigilance module on management and reporting of adverse reactions: http://t.co/Um38yItccv","id":"359223744142655488","created_at":"2013-07-22T08:09:49.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Um38yItccv","expanded_url":"http://bit.ly/136ooPC","display_url":"bit.ly/136ooPC"}],"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"359223744142655488","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"PRAC: one year of public health promotion and protection: http://t.co/80foENOv00","id":"358254805031981057","created_at":"2013-07-19T15:59:36.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/80foENOv00","expanded_url":"http://bit.ly/14mS686","display_url":"bit.ly/14mS686"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"358254805031981057","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published the highlights from our #veterinary committee; includes two new #medicines recommended for #dogs: http://t.co/tHrmvzgmnY","id":"358249837965225984","created_at":"2013-07-19T15:39:51.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/tHrmvzgmnY","expanded_url":"http://bit.ly/12BrECr","display_url":"bit.ly/12BrECr"}],"hashtags":[{"start":40,"end":51,"tag":"veterinary"},{"start":80,"end":90,"tag":"medicines"},{"start":107,"end":112,"tag":"dogs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358249837965225984","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've just published the agenda for our workshop on conflicts of interests on 6 September: http://t.co/1jnoE1gOSL","id":"358231081008377856","created_at":"2013-07-19T14:25:20.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/1jnoE1gOSL","expanded_url":"http://bit.ly/18sxkqp","display_url":"bit.ly/18sxkqp"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358231081008377856","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe_TB: Toppling #Tuberculosis in Europe | #TBChat from our Regional Director http://t.co/lOl0UOwpLA","id":"358213372283985920","created_at":"2013-07-19T13:14:57.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/lOl0UOwpLA","expanded_url":"http://www.huffingtonpost.com/zsuzsanna-jakab/pushing-to-topple-tb-for-_b_3617210.html","display_url":"huffingtonpost.com/zsuzsanna-jaka…"}],"hashtags":[{"start":28,"end":41,"tag":"Tuberculosis"},{"start":54,"end":61,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":[{"start":45,"end":50,"probability":0.9913,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358213372283985920","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"358209529881694208"}],"attachments":{"media_keys":{}}},{"text":"Our finalised guideline on investigating medicines for the treatment of urinary #incontinence is now available: http://t.co/6xGm78C5Tx","id":"358182641440260096","created_at":"2013-07-19T11:12:51.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/6xGm78C5Tx","expanded_url":"http://bit.ly/15saNnQ","display_url":"bit.ly/15saNnQ"}],"hashtags":[{"start":80,"end":93,"tag":"incontinence"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358182641440260096","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Send us you comments on our draft guideline on medicines for irritable bowel syndrome #IBS: deadline 15 January 2014: http://t.co/2yLJKxeWhb","id":"358182287944331264","created_at":"2013-07-19T11:11:26.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/2yLJKxeWhb","expanded_url":"http://bit.ly/12RwWZq","display_url":"bit.ly/12RwWZq"}],"hashtags":[{"start":86,"end":90,"tag":"IBS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358182287944331264","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our human medicine committee, the #CHMP, is meeting next week. We're publishing the highlights on Friday: http://t.co/BVe20M2eXv","id":"358182064333398016","created_at":"2013-07-19T11:10:33.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/BVe20M2eXv","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":34,"end":39,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358182064333398016","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"358181657720786945","created_at":"2013-07-19T11:08:56.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":45,"end":56,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358181657720786945","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Marketing-authorisation holders:don't forget to use the updated application forms for variations from 4 August: http://t.co/7eMVGXSiZi","id":"358181415222910976","created_at":"2013-07-19T11:07:58.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/7eMVGXSiZi","expanded_url":"http://bit.ly/18obr8n","display_url":"bit.ly/18obr8n"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358181415222910976","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've just published our guideline on medicines for the treatment of urinary #incontinence: http://t.co/6xGm78C5Tx","id":"358172232842887170","created_at":"2013-07-19T10:31:29.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/6xGm78C5Tx","expanded_url":"http://bit.ly/15saNnQ","display_url":"bit.ly/15saNnQ"}],"hashtags":[{"start":77,"end":90,"tag":"incontinence"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"358172232842887170","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've released a guideline on medicines for irritable bowel syndrome for consultation: deadline 15 January 2014: http://t.co/2yLJKxeWhb","id":"358171586022490112","created_at":"2013-07-19T10:28:55.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/2yLJKxeWhb","expanded_url":"http://bit.ly/12RwWZq","display_url":"bit.ly/12RwWZq"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"358171586022490112","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @WHO: Scientists have identified 5 unique #hepatitis viruses, identified by the letters A, B, C, D, and E. Q&amp;A http://t.co/gcbTEhRESd #W…","id":"358137881497726976","created_at":"2013-07-19T08:14:59.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/gcbTEhRESd","expanded_url":"http://goo.gl/1mWnO","display_url":"goo.gl/1mWnO"}],"hashtags":[{"start":45,"end":55,"tag":"hepatitis"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":110,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358137881497726976","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"358137776308363265"}],"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Just over a week until #worldhepday! Need materials? You can get them from our website http://t.co/2DoTgHu8OL","id":"358137865622265856","created_at":"2013-07-19T08:14:55.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/2DoTgHu8OL","expanded_url":"http://www.worldhepatitisalliance.org/WorldHepatitisDay/WHD2013/CampaignMaterials2013.aspx","display_url":"worldhepatitisalliance.org/WorldHepatitis…"}],"hashtags":[{"start":41,"end":53,"tag":"worldhepday"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"358137865622265856","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"358136575760154625"}],"attachments":{"media_keys":{}}},{"text":"Next week is the July #CHMP meeting. We're publishing the main outcomes on Friday: http://t.co/BVe20M2eXv","id":"358137291010609152","created_at":"2013-07-19T08:12:38.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/BVe20M2eXv","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":22,"end":27,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"358137291010609152","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've extended the public consultation on our inventory of #paediatric needs to 26 July - one week left to comment: http://t.co/DI2O8H4btl","id":"358136462316806144","created_at":"2013-07-19T08:09:21.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":59,"end":70,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"358136462316806144","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"From 4 August, marketing-authorisation holders will need to use the updated application forms for variations: http://t.co/7eMVGXSiZi","id":"358135964813635586","created_at":"2013-07-19T08:07:22.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/7eMVGXSiZi","expanded_url":"http://bit.ly/18obr8n","display_url":"bit.ly/18obr8n"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"358135964813635586","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Commissioner Máire Geoghegan-Quinn on Horizon 2020 #H2020 #H2020Views http://t.co/ubXappD6ue","id":"357871204671455232","created_at":"2013-07-18T14:35:18.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/ubXappD6ue","expanded_url":"http://youtu.be/cAd-US3MsfE?a","display_url":"youtu.be/cAd-US3MsfE?a"}],"hashtags":[{"start":72,"end":78,"tag":"H2020"},{"start":79,"end":90,"tag":"H2020Views"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357871204671455232","source":"TweetDeck","lang":"ca","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357862569580564480"}],"attachments":{"media_keys":{}}},{"text":"RT @IlaeWeb: Classification of hippocampal sclerosis in temporal lobe epilepsy - Report in new issue of Epilepsia: http://t.co/LcqICCmShY","id":"357830838773624832","created_at":"2013-07-18T11:54:54.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/LcqICCmShY","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/epi.12220/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1111/ep…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":[{"start":104,"end":112,"probability":0.3575,"type":"Other","normalized_text":"Epilepsia"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357830838773624832","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357830468156145664"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Vaccine against human papillomavirus (HPV) types 16 &amp; 18 also protects strongly against oral #HPV infections http://t.co/LDKwhZNWMU","id":"357830730938073088","created_at":"2013-07-18T11:54:29.000Z","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/LDKwhZNWMU","expanded_url":"http://goo.gl/V8mmo","display_url":"goo.gl/V8mmo"}],"hashtags":[{"start":106,"end":110,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":133,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357830730938073088","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357829792021757954"}],"attachments":{"media_keys":{}}},{"text":"Public consultation on inventory of #paediatric needs extended to 26 July because our website was down this week: http://t.co/DI2O8H4btl","id":"357820312190058497","created_at":"2013-07-18T11:13:05.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":36,"end":47,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357820312190058497","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Stefano Marino is our new Head of Legal Service: http://t.co/DrqjVnkd6I","id":"357817452329054208","created_at":"2013-07-18T11:01:43.000Z","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/DrqjVnkd6I","expanded_url":"http://bit.ly/15ow4yO","display_url":"bit.ly/15ow4yO"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":13,"probability":0.9772,"type":"Person","normalized_text":"Stefano Marino"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"357817452329054208","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: #IFAHEurope Perspectives newsletter (July) now out: http://t.co/9nRjBjHL5Y Feel free to retweet/share #animalhealth #EU @EU…","id":"357797077637951488","created_at":"2013-07-18T09:40:45.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/9nRjBjHL5Y","expanded_url":"http://bit.ly/13Qe8RM","display_url":"bit.ly/13Qe8RM"}],"hashtags":[{"start":16,"end":27,"tag":"IFAHEurope"},{"start":118,"end":131,"tag":"animalhealth"},{"start":132,"end":135,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357797077637951488","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357795281321992192"}],"attachments":{"media_keys":{}}},{"text":"We welcome Stefano Marino as our new Head of Legal Service: http://t.co/DrqjVnkd6I","id":"357788498054492160","created_at":"2013-07-18T09:06:39.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/DrqjVnkd6I","expanded_url":"http://bit.ly/15ow4yO","display_url":"bit.ly/15ow4yO"}],"hashtags":{},"mentions":{},"annotations":[{"start":11,"end":24,"probability":0.9709,"type":"Person","normalized_text":"Stefano Marino"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"357788498054492160","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We are now able to publish content to our website again. We're just ironing out the last few problems with documents already published.","id":"357788342265462784","created_at":"2013-07-18T09:06:02.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357502255412428802","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"357506635725406208"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"@HJF29088181 Thanks again for your suggestion - we're going to start sending these 'heads-up' tweets this week.","id":"357532938855907330","created_at":"2013-07-17T16:11:09.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350569724070993920","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"350571937178730497"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"The website is live again now. Please bear with us while we continue to work on our technical problems.","id":"357506635725406208","created_at":"2013-07-17T14:26:38.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"357502255412428802","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"357502255412428802"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"Our website is down again due to ongoing technical problems. We apologise for the inconvenience.","id":"357502255412428802","created_at":"2013-07-17T14:09:14.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"357502255412428802","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: European Medicines Agency creates Healthcare Professionals' Working Party http://t.co/86BizoxcQc @EMA_News","id":"357479129442025473","created_at":"2013-07-17T12:37:20.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/86BizoxcQc","expanded_url":"http://bit.ly/15MrjB5","display_url":"bit.ly/15MrjB5"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":108,"end":117,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357479129442025473","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357462098944606210"}],"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Need a reason to spread the word about #Worldhepday 28th July? Viral hepatitis is 8th leading cause of death globally. Kn…","id":"357443426947563520","created_at":"2013-07-17T10:15:28.000Z","entities":{"urls":{},"hashtags":[{"start":57,"end":69,"tag":"Worldhepday"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357443426947563520","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357430928521441280"}],"attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: Wondering how a single #EU licensing system for #veterinarymedicine could work? Here's how we see it: http://t.co/0myI9DmNhF","id":"357419299876913152","created_at":"2013-07-17T08:39:36.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/0myI9DmNhF","expanded_url":"http://bit.ly/13iAs3s","display_url":"bit.ly/13iAs3s"}],"hashtags":[{"start":39,"end":42,"tag":"EU"},{"start":64,"end":83,"tag":"veterinarymedicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357419299876913152","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357417379661230082"}],"attachments":{"media_keys":{}}},{"text":"@HJF29088181 We're still having technical problems. The site is live but we still can't publish to it. We'll provide an update ASAP.","id":"357418757100023809","created_at":"2013-07-17T08:37:26.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"356739492599701504","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"357182538780901379"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"RT @IlaeWeb: Seizure control and treatment changes in pregnancy - Epilepsia: http://t.co/fdBWv0qgJ4","id":"357174553039994881","created_at":"2013-07-16T16:27:04.000Z","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/fdBWv0qgJ4","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/epi.12302/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1111/ep…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357174553039994881","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357170712416489473"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #Medicines manufacturing: consultation to revise annex on certification by qualified person &amp;batch release. Ddl 15Nov http:/…","id":"357155438300631040","created_at":"2013-07-16T15:11:06.000Z","entities":{"urls":{},"hashtags":[{"start":15,"end":25,"tag":"Medicines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357155438300631040","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357151252066480131"}],"attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Review of medicines containing zolpidem http://t.co/xqBGzjWtIw","id":"357155275708440580","created_at":"2013-07-16T15:10:28.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/xqBGzjWtIw","expanded_url":"http://bit.ly/13qmQyE","display_url":"bit.ly/13qmQyE"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"357155275708440580","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO report: Important topics for future pharma research: develop new options of meds in light of increasing resistance of common m…","id":"357154697557188609","created_at":"2013-07-16T15:08:10.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357154697557188609","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357140474928173057"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: New WHO report calls for pharmaceutical researchers to adjust research and development efforts to account for #ageing population","id":"357131430578499584","created_at":"2013-07-16T13:35:42.000Z","entities":{"urls":{},"hashtags":[{"start":119,"end":126,"tag":"ageing"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357131430578499584","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357129752324222977"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Public consultation on applications for designation of #orphan #medicines - deadline 30.09.2013 http://t.co/piiLaU86Pp","id":"357130783867158529","created_at":"2013-07-16T13:33:08.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/piiLaU86Pp","expanded_url":"http://bit.ly/17idxoY","display_url":"bit.ly/17idxoY"}],"hashtags":[{"start":70,"end":77,"tag":"orphan"},{"start":78,"end":88,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357130783867158529","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357116600660402177"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: Hot off the press: ESMO Guidelines on early &amp; locally adv. non-small-cell lung cancer #NSCLC http://t.co/GWZ0VvvzcY","id":"357114893385736192","created_at":"2013-07-16T12:30:00.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/GWZ0VvvzcY","expanded_url":"http://ow.ly/n0vNJ","display_url":"ow.ly/n0vNJ"}],"hashtags":[{"start":102,"end":108,"tag":"NSCLC"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"357114893385736192","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"357112447015981058"}],"attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: Recommendations for frequency of liver-function tests in patients treated with Votrient (pazopanib) http://t.co/xXNDxzeaty","id":"357114072136810497","created_at":"2013-07-16T12:26:44.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/xXNDxzeaty","expanded_url":"http://www.urpl.gov.pl/pl-komunikaty-bezp/zalecenia-dotyczace-czestosci-badan-czynnosci-watroby-u-pacjentow-leczonych-produktem-votrient-pazopanib-2","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":94,"end":101,"probability":0.3446,"type":"Person","normalized_text":"Votrient"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"357114072136810497","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our website is now back up and running. Apologies for the inconvenience.","id":"357091472404774912","created_at":"2013-07-16T10:56:56.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"356739492599701504","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"356805472726163457"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"Our website will be down until at least tomorrow morning because of ongoing technical problems. We apologise for the inconvenience.","id":"356805472726163457","created_at":"2013-07-15T16:00:28.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"356739492599701504","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"356766910630735872"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"We've had to take our website down temporarily while we try to resolve the problems we're having. Apologies for the inconvenience.","id":"356766910630735872","created_at":"2013-07-15T13:27:14.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"356739492599701504","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"356739492599701504"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"RT @ECDC_EU: ESCAIDE 2013  online registration now open; for details, visit:  http://t.co/oe3J6w3y8O","id":"356766460900679682","created_at":"2013-07-15T13:25:27.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/oe3J6w3y8O","expanded_url":"http://bit.ly/12DlAbq","display_url":"bit.ly/12DlAbq"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"356766460900679682","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"356762400525008897"}],"attachments":{"media_keys":{}}},{"text":"We published the PRAC meeting highlights on Friday: http://t.co/WfHfcITnhT","id":"356747796101070848","created_at":"2013-07-15T12:11:17.000Z","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/WfHfcITnhT","expanded_url":"http://bit.ly/157Ab24","display_url":"bit.ly/157Ab24"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"356747796101070848","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We're having some problems with documents published on our website. Please bear with us while we try to resolve the issue.","id":"356739492599701504","created_at":"2013-07-15T11:38:17.000Z","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"356739492599701504","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat to healthcare http://t.co/Qfif5wSvcs","id":"356697489660841984","created_at":"2013-07-15T08:51:23.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/Qfif5wSvcs","expanded_url":"http://bit.ly/18g1lGn","display_url":"bit.ly/18g1lGn"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"356697489660841984","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"356696300122673152"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA approves new treatment for a type of late-stage lung cancer http://t.co/qhO99Kk3ov","id":"355679755942625280","created_at":"2013-07-12T13:27:16.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/qhO99Kk3ov","expanded_url":"http://1.usa.gov/1ayj1RP","display_url":"1.usa.gov/1ayj1RP"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8815,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355679755942625280","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355679650950819840"}],"attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","id":"355661943379468289","created_at":"2013-07-12T12:16:29.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355661943379468289","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355658016399425537"}],"attachments":{"media_keys":{}}},{"text":"We've just published the PRAC meeting highlights: http://t.co/WfHfcITnhT","id":"355650029005971459","created_at":"2013-07-12T11:29:09.000Z","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/WfHfcITnhT","expanded_url":"http://bit.ly/157Ab24","display_url":"bit.ly/157Ab24"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355650029005971459","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Only a few more days to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"355649576167936000","created_at":"2013-07-12T11:27:21.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":58,"end":69,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355649576167936000","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Only a few more days to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"355649487424847874","created_at":"2013-07-12T11:27:00.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":65,"end":74,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"355649487424847874","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Only a few more days to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"355649407737274368","created_at":"2013-07-12T11:26:41.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":65,"end":71,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355649407737274368","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Only a few more days to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"355648974746697728","created_at":"2013-07-12T11:24:57.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":65,"end":75,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355648974746697728","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"355598955331063808","created_at":"2013-07-12T08:06:12.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":51,"end":62,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"355598955331063808","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"355598853434642432","created_at":"2013-07-12T08:05:48.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":58,"end":67,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"355598853434642432","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"355598717488865280","created_at":"2013-07-12T08:05:15.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":58,"end":64,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"355598717488865280","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last few days to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"355598449393156096","created_at":"2013-07-12T08:04:11.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":58,"end":68,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355598449393156096","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: En Espanol: #FDA approves label changes to include intestinal problems linked to olmesartan medoxomil. http://t.co/y0sAR…","id":"355343877198192640","created_at":"2013-07-11T15:12:37.000Z","entities":{"urls":{},"hashtags":[{"start":31,"end":35,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355343877198192640","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355343491603251201"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Polish medicines agency: withdrawal of hydroxyethyl-starch products  http://t.co/faYFN4A0BM","id":"355304803443802112","created_at":"2013-07-11T12:37:21.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/faYFN4A0BM","expanded_url":"http://www.rynekzdrowia.pl/Farmacja/URPL-o-wycofaniu-produktow-z-hydroksyetyloskrobia,132222,6.html#.Ud6j4Q3kzPg.twitter","display_url":"rynekzdrowia.pl/Farmacja/URPL-…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"355304803443802112","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Polish medicines agency info on ban of marketing of infusion solutions containing hydroxyethyl starch http://t.co/G7hst6VYEf","id":"355304548212019201","created_at":"2013-07-11T12:36:20.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/G7hst6VYEf","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-11-lipca-2013-roku-w-zwiazku-z-decyzjami-glownego-inspektora-farmaceutycznego-zakazujacymi-wprowadzania-do-obrotu-roz","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"355304548212019201","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRApress: MHRA issues precautionary recall of medicines http://t.co/Xnvv1KrXRm","id":"355295998647615488","created_at":"2013-07-11T12:02:21.000Z","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/Xnvv1KrXRm","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON296424","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355295998647615488","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355295699748917249"}],"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Class 2 Medicines recall (Action Within 48 Hours): Multiple products - Pinewood Laboratories Limited (EL (13)A... http:/…","id":"355295867034546178","created_at":"2013-07-11T12:01:50.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":90,"end":118,"probability":0.3311,"type":"Organization","normalized_text":"Pinewood Laboratories Limited"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355295867034546178","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355289937710555136"}],"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Class 2 Drug Alert (Action Within 48 Hours): Multiple products - Wockhardt UK Limited (EL (13)A/19) http://t.co/5pnomddh…","id":"355295850852925441","created_at":"2013-07-11T12:01:46.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355295850852925441","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"355289859532926977"}],"attachments":{"media_keys":{}}},{"text":"Two webinars coming up to train applicants on electronic submission of single-assessment #PSURs: http://t.co/CfzhJtroNL","id":"355280977536364544","created_at":"2013-07-11T11:02:40.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/CfzhJtroNL","expanded_url":"http://bit.ly/12ojoct","display_url":"bit.ly/12ojoct"}],"hashtags":[{"start":89,"end":95,"tag":"PSURs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355280977536364544","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Just one more day to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"355280838415495168","created_at":"2013-07-11T11:02:07.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":35,"end":43,"tag":"vacancy"},{"start":86,"end":97,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355280838415495168","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Just one more day to apply for our #vacancy for a resourcing assistant to support our IT office: http://t.co/LjHMsWmR8d","id":"355280759206068225","created_at":"2013-07-11T11:01:48.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":35,"end":43,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355280759206068225","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Just one more day to apply for our #vacancy for a #scientist to work in #quality of medicines: http://t.co/smbCJX2nuX","id":"355280676997693441","created_at":"2013-07-11T11:01:28.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":35,"end":43,"tag":"vacancy"},{"start":50,"end":60,"tag":"scientist"},{"start":72,"end":80,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355280676997693441","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@trinevillemann As Stamaril is authorised nationally the issue would need to be officially referred to us. See: http://t.co/y7P9Z9gMFL","id":"355273489130856448","created_at":"2013-07-11T10:32:55.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/y7P9Z9gMFL","expanded_url":"http://bit.ly/133cMvv","display_url":"bit.ly/133cMvv"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":19,"end":26,"probability":0.3232,"type":"Organization","normalized_text":"Stamaril"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355269226325479426"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"We're organising webinars to train applicants on electronic submission of single-assessment #PSURs: http://t.co/CfzhJtroNL","id":"355271290992607232","created_at":"2013-07-11T10:24:11.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/CfzhJtroNL","expanded_url":"http://bit.ly/12ojoct","display_url":"bit.ly/12ojoct"}],"hashtags":[{"start":92,"end":98,"tag":"PSURs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"355271290992607232","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@trinevillemann Information on safety monitoring of medicines is here: http://t.co/MpdmGvj0Ui.","id":"355269226325479426","created_at":"2013-07-11T10:15:58.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/MpdmGvj0Ui","expanded_url":"http://bit.ly/16tC1te","display_url":"bit.ly/16tC1te"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355267503389286400"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann If Stamaril is marketed in Greece, it will have a Greek marketing authorisation; not regulated centrally at EU level.","id":"355265970102738944","created_at":"2013-07-11T10:03:02.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":19,"end":26,"probability":0.395,"type":"Person","normalized_text":"Stamaril"},{"start":43,"end":48,"probability":0.995,"type":"Place","normalized_text":"Greece"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355265419902320643"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann Medicines in Greece are marketed in accordance with Greek and EU law, not our rules and regulations.","id":"355265542023692288","created_at":"2013-07-11T10:01:20.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":29,"end":34,"probability":0.9964,"type":"Place","normalized_text":"Greece"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355264705377468416"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"One day left to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"355262832020946944","created_at":"2013-07-11T09:50:34.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":30,"end":38,"tag":"vacancy"},{"start":81,"end":92,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355262832020946944","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One day left to apply for our #vacancy for a resourcing assistant to support our IT office: http://t.co/LjHMsWmR8d","id":"355262760730361856","created_at":"2013-07-11T09:50:17.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":30,"end":38,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355262760730361856","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One day left to apply for our #vacancy for a #scientist to work in #quality of medicines: http://t.co/smbCJX2nuX","id":"355262661312786432","created_at":"2013-07-11T09:49:53.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":30,"end":38,"tag":"vacancy"},{"start":45,"end":55,"tag":"scientist"},{"start":67,"end":75,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"355262661312786432","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@trinevillemann Referrals are one-off. This one ended in July 2006.","id":"355261524983549952","created_at":"2013-07-11T09:45:22.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355261359857991680"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann No, we do not deal with nationally authorised medicines unless referred to us. Please contact relation@eof.gr.","id":"355258657795084288","created_at":"2013-07-11T09:33:59.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355258184644050945"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann No Greek authorisations for Stamaril were included in this referral in 2006.","id":"355258468476788736","created_at":"2013-07-11T09:33:13.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":44,"end":51,"probability":0.3868,"type":"Person","normalized_text":"Stamaril"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355256131406405632"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann To get detailed information on the marketing authorisation granted in Greece, you will need to contact relation@eof.gr.","id":"355257027993411584","created_at":"2013-07-11T09:27:30.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":86,"end":91,"probability":0.9942,"type":"Place","normalized_text":"Greece"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann We only deal with centrally authorised medicines and referrals: http://t.co/U6hy4UKtZD.","id":"355254581632049154","created_at":"2013-07-11T09:17:47.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/U6hy4UKtZD","expanded_url":"http://bit.ly/18P5cgv","display_url":"bit.ly/18P5cgv"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann We only deal with centrally authorised meds unless referred to us. Contact the Greek agency for info on Greek authorisation.","id":"355250683731128321","created_at":"2013-07-11T09:02:17.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355249962784784385"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@trinevillemann The referral was in 2006; no authorisations in Greece to include. Contact the Greek agency for more info: relation@eof.gr.","id":"355243854540177408","created_at":"2013-07-11T08:35:09.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":63,"end":68,"probability":0.9951,"type":"Place","normalized_text":"Greece"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355015922769068032"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@HJF29088181 Thanks for the feedback - we'll look into it.","id":"355004047457128448","created_at":"2013-07-10T16:42:15.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351637895188193282","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355002073701552131"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"@xOneStepBehind @WHO Try contacting your national regulator. If you're in Norway, email post@legemiddelverket.no http://t.co/gaXR2yqWLp","id":"355003675850190850","created_at":"2013-07-10T16:40:46.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/gaXR2yqWLp","expanded_url":"http://bit.ly/1531o5P","display_url":"bit.ly/1531o5P"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"annotations":[{"start":74,"end":79,"probability":0.9931,"type":"Place","normalized_text":"Norway"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"354573717747142657","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"354573717747142657"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"40722651"},{"text":"@xOneStepBehind @WHO E-cigarettes are not currently classified as medicinal products so are outside our remit...","id":"355003253622194177","created_at":"2013-07-10T16:39:05.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354573717747142657","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"354573717747142657"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"40722651"},{"text":"@trinevillemann Otherwise, try contacting the Greek medicines agency directly at relation@eof.gr for more info on the Greek authorisation.","id":"355000975758606340","created_at":"2013-07-10T16:30:02.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"355000370117869568"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"@trinevillemann Stamaril is not centrally authorised in the EU but we did recommend harmonised information in 2006: http://t.co/0NW5KHaluK","id":"355000370117869568","created_at":"2013-07-10T16:27:38.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/0NW5KHaluK","expanded_url":"http://bit.ly/15wqYlM","display_url":"bit.ly/15wqYlM"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":60,"end":61,"probability":0.3822,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351645431878520835","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"351645431878520835"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"text":"@HJF29088181 CHMP highlights only include new medicines &amp; indications, not routes of administration. Keep an eye on http://t.co/BX7PMF7vVv","id":"354999459001806848","created_at":"2013-07-10T16:24:01.000Z","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/BX7PMF7vVv","expanded_url":"http://bit.ly/1bofovI","display_url":"bit.ly/1bofovI"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"351637895188193282","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"351638727124201472"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"RT @myCORDIS: Novel #HIV vaccines via novel routes http://t.co/lZwZyqYQMj @upmc #fp7","id":"354995334688153601","created_at":"2013-07-10T16:07:37.000Z","entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/lZwZyqYQMj","expanded_url":"http://owl.li/mKctL","display_url":"owl.li/mKctL"}],"hashtags":[{"start":20,"end":24,"tag":"HIV"},{"start":80,"end":84,"tag":"fp7"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":74,"end":79,"username":"UPMC","id":"3844343603"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354995334688153601","source":"TweetDeck","lang":"ca","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"354994984258248706"}],"attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA to hold public consultations over coming weeks in areas of nutrition,FCMs,pesticides,plant health,animal welfare,feed ad…","id":"354995061378924544","created_at":"2013-07-10T16:06:32.000Z","entities":{"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354995061378924544","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"354993532550905858"}],"attachments":{"media_keys":{}}},{"text":"European Medicines Agency creates Healthcare Professionals’ Working Party: http://t.co/y2H0FJKx6H","id":"354607016880246785","created_at":"2013-07-09T14:24:35.000Z","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/y2H0FJKx6H","expanded_url":"http://bit.ly/13IQndb","display_url":"bit.ly/13IQndb"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"354607016880246785","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"354240455212400640","created_at":"2013-07-08T14:08:00.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":51,"end":62,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354240455212400640","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"354240330738044928","created_at":"2013-07-08T14:07:30.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":58,"end":67,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354240330738044928","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"354240234667520000","created_at":"2013-07-08T14:07:08.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":58,"end":64,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354240234667520000","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"354240111732465664","created_at":"2013-07-08T14:06:38.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":58,"end":68,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354240111732465664","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"354157290384928768","created_at":"2013-07-08T08:37:32.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":51,"end":62,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"354157290384928768","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"354157181089755136","created_at":"2013-07-08T08:37:06.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":58,"end":67,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354157181089755136","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"354157091784626177","created_at":"2013-07-08T08:36:45.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":58,"end":64,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354157091784626177","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"354157010398351362","created_at":"2013-07-08T08:36:25.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":58,"end":68,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"354157010398351362","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The registration for the workshop on Conflicts of Interests on 6 September in now open: http://t.co/LSwyMzECTh","id":"353165826167275523","created_at":"2013-07-05T14:57:49.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/LSwyMzECTh","expanded_url":"http://bit.ly/18AnKRo","display_url":"bit.ly/18AnKRo"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353165826167275523","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"353165589981822976","created_at":"2013-07-05T14:56:52.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":82,"end":93,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353165589981822976","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to apply for our #vacancy for a resourcing assistant to support our IT office. Deadline: 12 July 2013: http://t.co/LjHMsWmR8d","id":"353163996637036545","created_at":"2013-07-05T14:50:32.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353163996637036545","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","id":"353163724019859457","created_at":"2013-07-05T14:49:27.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"},{"start":68,"end":76,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"353163724019859457","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Registration opens for workshop on Conflicts of Interests on 6 September: http://t.co/LSwyMzECTh","id":"353090121911906305","created_at":"2013-07-05T09:56:59.000Z","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/LSwyMzECTh","expanded_url":"http://bit.ly/18AnKRo","display_url":"bit.ly/18AnKRo"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353090121911906305","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"353075212176199680","created_at":"2013-07-05T08:57:45.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":82,"end":93,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353075212176199680","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to apply for our #vacancy for a resourcing assistant to support our IT office. Deadline: 12 July 2013: http://t.co/LjHMsWmR8d","id":"353074347642073090","created_at":"2013-07-05T08:54:18.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"353074347642073090","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","id":"353073942942060544","created_at":"2013-07-05T08:52:42.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"},{"start":68,"end":76,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"353073942942060544","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our draft concept paper on manufacture of the finished dosage form is open for consultation until 31 Dec 2013: http://t.co/NkVFxTBYin","id":"352801590698188800","created_at":"2013-07-04T14:50:28.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"352801590698188800","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Last day to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"352801207175233536","created_at":"2013-07-04T14:48:57.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":55,"end":66,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"352801207175233536","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Concept paper on manufacture of the finished dosage form open for consultation: http://t.co/NkVFxTBYin","id":"352720304407187456","created_at":"2013-07-04T09:27:28.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"352720304407187456","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One day left to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"352704826385252352","created_at":"2013-07-04T08:25:58.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":59,"end":70,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"352704826385252352","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"The ENCePP guide on methodological standards in pharmacoepidemiology has been revised: http://t.co/4K6gZL6L7k","id":"352429904073203712","created_at":"2013-07-03T14:13:31.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4K6gZL6L7k","expanded_url":"http://bit.ly/15fPfwj","display_url":"bit.ly/15fPfwj"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"352429904073203712","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Nuedexta used to treat the symptoms of #pseudobulbar affect in adults: http://t.co/5xGu0Hppj4","id":"352071819420909568","created_at":"2013-07-02T14:30:37.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/5xGu0Hppj4","expanded_url":"http://bit.ly/10xbYSO","display_url":"bit.ly/10xbYSO"}],"hashtags":[{"start":42,"end":51,"tag":"Nuedexta"},{"start":82,"end":95,"tag":"pseudobulbar"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"352071819420909568","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Xtandi, used to treat adult men with #cancer of the prostate: http://t.co/YnZ6nJIE7M","id":"352060584344297473","created_at":"2013-07-02T13:45:58.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/YnZ6nJIE7M","expanded_url":"http://bit.ly/15dkQib","display_url":"bit.ly/15dkQib"}],"hashtags":[{"start":42,"end":49,"tag":"Xtandi"},{"start":80,"end":87,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"352060584344297473","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"#Falsified medicines directive requires written confirmation for importation of active substances http://t.co/WRGW3Va8JC","id":"352052775942762496","created_at":"2013-07-02T13:14:57.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/WRGW3Va8JC","expanded_url":"http://bit.ly/1cM8jTx","display_url":"bit.ly/1cM8jTx"}],"hashtags":[{"start":0,"end":10,"tag":"Falsified"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"352052775942762496","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Revised note for guidance on clinical investigation of medicines for treatment of #asthma (6 month consultation): http://t.co/iOp2LRSdcF","id":"352008889966936064","created_at":"2013-07-02T10:20:34.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/iOp2LRSdcF","expanded_url":"http://bit.ly/12gKmPq","display_url":"bit.ly/12gKmPq"}],"hashtags":[{"start":82,"end":89,"tag":"asthma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"352008889966936064","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"351736684456579073","created_at":"2013-07-01T16:18:55.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":52,"end":63,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351736684456579073","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"351736589535297536","created_at":"2013-07-01T16:18:32.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":59,"end":68,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351736589535297536","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"351736490402906112","created_at":"2013-07-01T16:18:08.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":59,"end":65,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351736490402906112","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"351736414238547969","created_at":"2013-07-01T16:17:50.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":59,"end":69,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351736414238547969","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We are inviting comments on revised guidance on clinical investigation of medicines for the treatment of #asthma: http://t.co/iOp2LRSdcF","id":"351729092137197568","created_at":"2013-07-01T15:48:45.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/iOp2LRSdcF","expanded_url":"http://bit.ly/12gKmPq","display_url":"bit.ly/12gKmPq"}],"hashtags":[{"start":105,"end":112,"tag":"asthma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"351729092137197568","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Concept paper on statistical methodology for the comparative assessment of quality attributes open for consultation: http://t.co/cPzrMeq9Ln","id":"351650849648422912","created_at":"2013-07-01T10:37:50.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"351650849648422912","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Our draft guideline on adjustment for baseline covariates is open for consultation until 31 Dec 2013: http://t.co/KmsKTxAmuJ","id":"351650357425881091","created_at":"2013-07-01T10:35:53.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/KmsKTxAmuJ","expanded_url":"http://bit.ly/11NvyeK","display_url":"bit.ly/11NvyeK"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351650357425881091","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our draft inventory of #paediatric needs in infectious diseases: http://t.co/DI2O8H4btl","id":"351649945465520128","created_at":"2013-07-01T10:34:14.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":52,"end":63,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351649945465520128","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","id":"351649801722531841","created_at":"2013-07-01T10:33:40.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":59,"end":68,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"351649801722531841","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on the draft herbal monograph on #Panax ginseng (ginseng root): http://t.co/0p9jWqykV8","id":"351649666993094656","created_at":"2013-07-01T10:33:08.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/0p9jWqykV8","expanded_url":"http://bit.ly/128CfEA","display_url":"bit.ly/128CfEA"}],"hashtags":[{"start":59,"end":65,"tag":"Panax"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351649666993094656","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on the draft herbal monograph on #Phaseolus vulgaris (green bean pod): http://t.co/CWurT9xkCC","id":"351649539754704896","created_at":"2013-07-01T10:32:38.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/CWurT9xkCC","expanded_url":"http://bit.ly/12qLBi6","display_url":"bit.ly/12qLBi6"}],"hashtags":[{"start":59,"end":69,"tag":"Phaseolus"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351649539754704896","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We welcome #croatia to the European medicines network http://t.co/fw6EbbQd3a","id":"351649135897751554","created_at":"2013-07-01T10:31:01.000Z","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/fw6EbbQd3a","expanded_url":"http://bit.ly/11XW7KA","display_url":"bit.ly/11XW7KA"}],"hashtags":[{"start":11,"end":19,"tag":"croatia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"351649135897751554","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We published the CHMP highlights on Friday: http://t.co/8yFvm3eCLG","id":"351637895188193282","created_at":"2013-07-01T09:46:21.000Z","entities":{"urls":[{"start":44,"end":66,"url":"http://t.co/8yFvm3eCLG","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"351637895188193282","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommended approval of the fourth #advancedtherapy in Europe - #Provenge: http://t.co/qZVpiZJgAK","id":"351637750635700225","created_at":"2013-07-01T09:45:47.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/qZVpiZJgAK","expanded_url":"http://bit.ly/13bRmTW","display_url":"bit.ly/13bRmTW"}],"hashtags":[{"start":38,"end":54,"tag":"advancedtherapy"},{"start":67,"end":76,"tag":"Provenge"}],"mentions":{},"annotations":[{"start":58,"end":63,"probability":0.9828,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"351637750635700225","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommended approval of #Tafinlar for the treatment of metastatic #melanoma: http://t.co/26SIkqsooc","id":"351637105249763328","created_at":"2013-07-01T09:43:13.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/26SIkqsooc","expanded_url":"http://bit.ly/15MBkKY","display_url":"bit.ly/15MBkKY"}],"hashtags":[{"start":27,"end":36,"tag":"Tafinlar"},{"start":69,"end":78,"tag":"melanoma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"351637105249763328","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/HqLWfluEcI","id":"351636163234250752","created_at":"2013-07-01T09:39:29.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/HqLWfluEcI","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":41,"end":60,"tag":"monoclonalantibody"},{"start":61,"end":73,"tag":"biosimilars"},{"start":76,"end":84,"tag":"Remsima"},{"start":89,"end":99,"tag":"Inflectra"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"351636163234250752","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @ICH_news: Steering Committee takes measures aimed at increased transparency, step forward fostering openness. See press release http://…","id":"350629890611085312","created_at":"2013-06-28T15:00:54.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":[{"start":14,"end":31,"probability":0.8731,"type":"Organization","normalized_text":"Steering Committee"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350629890611085312","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350626729469034499"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia ... http://t.co/92QDWvvcxc","id":"350622626210779137","created_at":"2013-06-28T14:32:03.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/92QDWvvcxc","expanded_url":"http://www.diabetologia-journal.org/","display_url":"diabetologia-journal.org"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350622626210779137","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350622355665600512"}],"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: The latest issue of Drug Safety Update (June 2013) is now available http://t.co/yqypzeCNoG","id":"350622589997166592","created_at":"2013-06-28T14:31:54.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/yqypzeCNoG","expanded_url":"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/index.htm","display_url":"mhra.gov.uk/Safetyinformat…"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":39,"end":56,"probability":0.688,"type":"Other","normalized_text":"Drug Safety Update"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350622589997166592","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350621152445607936"}],"attachments":{"media_keys":{}}},{"text":"RT @DrugInfoAssn: Strange Bedfellows No More: #EMA Moves Closer to #Payers #DIA2013 http://t.co/AAsu6Uvk9O","id":"350622559806570497","created_at":"2013-06-28T14:31:47.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/AAsu6Uvk9O","expanded_url":"http://blog.pharmexec.com/2013/06/27/strange-bedfellows-no-more-ema-moves-closer-to-payers/","display_url":"blog.pharmexec.com/2013/06/27/str…"}],"hashtags":[{"start":46,"end":50,"tag":"EMA"},{"start":67,"end":74,"tag":"Payers"},{"start":75,"end":83,"tag":"DIA2013"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350622559806570497","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350618647414317057"}],"attachments":{"media_keys":{}}},{"text":"We've released our draft guideline on adjustment for baseline covariates for consultation until 31 December 2013: http://t.co/KmsKTxAmuJ","id":"350616597032992768","created_at":"2013-06-28T14:08:05.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/KmsKTxAmuJ","expanded_url":"http://bit.ly/11NvyeK","display_url":"bit.ly/11NvyeK"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"350616597032992768","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Concept paper on statistical methodology for the comparative assessment of quality attributes open for consultation:  http://t.co/cPzrMeq9Ln","id":"350616162826059777","created_at":"2013-06-28T14:06:22.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"350616162826059777","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: #FDA participates in Interpol’s Pangea VI action to shutdown illegal online pharmacies #BeSafeRx http://t.co/8nEVyd3dyZ","id":"350610965781426176","created_at":"2013-06-28T13:45:42.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/8nEVyd3dyZ","expanded_url":"http://1.usa.gov/10l0CRN","display_url":"1.usa.gov/10l0CRN"}],"hashtags":[{"start":12,"end":16,"tag":"FDA"},{"start":99,"end":108,"tag":"BeSafeRx"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":33,"end":40,"probability":0.7451,"type":"Place","normalized_text":"Interpol"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350610965781426176","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350610868301598720"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Healthcare-associated risk of #MERS-CoV transmission appears significant. Read: http://t.co/jddHmwuMWs","id":"350605940908752896","created_at":"2013-06-28T13:25:44.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/jddHmwuMWs","expanded_url":"http://bit.ly/17Hl0lG","display_url":"bit.ly/17Hl0lG"}],"hashtags":[{"start":44,"end":49,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350605940908752896","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350600766924402688"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: Revised ESMO guidelines on Small-cell lung cancer now available http://t.co/XbhHzFVlkx","id":"350605619079819265","created_at":"2013-06-28T13:24:28.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/XbhHzFVlkx","expanded_url":"http://ow.ly/mtmUq","display_url":"ow.ly/mtmUq"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350605619079819265","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350596957032550401"}],"attachments":{"media_keys":{}}},{"text":"RT @FrancoisMaignen: #EMA Publication and access to CT data #AllTrials http://t.co/f8riGtN4zW","id":"350605102874247169","created_at":"2013-06-28T13:22:25.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/f8riGtN4zW","expanded_url":"http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500144730&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc","display_url":"ema.europa.eu/ema/doc_index.…"}],"hashtags":[{"start":21,"end":25,"tag":"EMA"},{"start":60,"end":70,"tag":"AllTrials"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350605102874247169","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350587443373809664"}],"attachments":{"media_keys":{}}},{"text":"RT @FrancoisMaignen: Warnings over 'unsafe' diet pills http://t.co/gsq5TFyqzS","id":"350605007323795457","created_at":"2013-06-28T13:22:02.000Z","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/gsq5TFyqzS","expanded_url":"http://bbc.in/17jVFLc","display_url":"bbc.in/17jVFLc"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350605007323795457","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350586727410302976"}],"attachments":{"media_keys":{}}},{"text":"RT @FrancoisMaignen: MHRA suspends use of hydroxyethyl starch (HES) drips http://t.co/yfUtPvpVbl","id":"350604874485989376","created_at":"2013-06-28T13:21:30.000Z","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/yfUtPvpVbl","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON287028","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350604874485989376","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350586470442074112"}],"attachments":{"media_keys":{}}},{"text":"RT @FrancoisMaignen: making data sharing real... http://t.co/5vJSut8IiV #AllTrials","id":"350604851702538240","created_at":"2013-06-28T13:21:25.000Z","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/5vJSut8IiV","expanded_url":"http://fb.me/2x7PVknKp","display_url":"fb.me/2x7PVknKp"}],"hashtags":[{"start":72,"end":82,"tag":"AllTrials"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350604851702538240","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350586216732819456"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA acts against fake websites selling unapproved drugs #BeSafeRx  http://t.co/5nAcaJmBq6","id":"350583475587395585","created_at":"2013-06-28T11:56:28.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/5nAcaJmBq6","expanded_url":"http://1.usa.gov/10l0CRN","display_url":"1.usa.gov/10l0CRN"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":76,"end":85,"tag":"BeSafeRx"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350583475587395585","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350581008103518208"}],"attachments":{"media_keys":{}}},{"text":"We've recommended approval of #Tafinlar for the treatment of metastatic #melanoma: http://t.co/26SIkqsooc","id":"350582623061544960","created_at":"2013-06-28T11:53:05.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/26SIkqsooc","expanded_url":"http://bit.ly/15MBkKY","display_url":"bit.ly/15MBkKY"}],"hashtags":[{"start":30,"end":39,"tag":"Tafinlar"},{"start":72,"end":81,"tag":"melanoma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350582623061544960","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've recommended approval of the fourth #advancedtherapy in Europe - #Provenge: http://t.co/qZVpiZJgAK","id":"350582240587161603","created_at":"2013-06-28T11:51:34.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/qZVpiZJgAK","expanded_url":"http://bit.ly/13bRmTW","display_url":"bit.ly/13bRmTW"}],"hashtags":[{"start":41,"end":57,"tag":"advancedtherapy"},{"start":70,"end":79,"tag":"Provenge"}],"mentions":{},"annotations":[{"start":61,"end":66,"probability":0.9828,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"350582240587161603","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/HqLWfluEcI","id":"350581781545762817","created_at":"2013-06-28T11:49:44.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/HqLWfluEcI","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":44,"end":63,"tag":"monoclonalantibody"},{"start":64,"end":76,"tag":"biosimilars"},{"start":79,"end":87,"tag":"Remsima"},{"start":92,"end":102,"tag":"Inflectra"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":2,"like_count":3,"quote_count":0},"conversation_id":"350581781545762817","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've just published the CHMP highlights: http://t.co/8yFvm3eCLG","id":"350581290778624000","created_at":"2013-06-28T11:47:47.000Z","entities":{"urls":[{"start":42,"end":64,"url":"http://t.co/8yFvm3eCLG","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":2,"like_count":2,"quote_count":0},"conversation_id":"350581290778624000","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two days left to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","id":"350572777423634432","created_at":"2013-06-28T11:13:58.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350572777423634432","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Tomorrow some of our IT systems will be unavailable due to maintenance. We apologise for any inconvenience: http://t.co/zqcRWqsUAL","id":"350571882807959554","created_at":"2013-06-28T11:10:24.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/zqcRWqsUAL","expanded_url":"http://bit.ly/13d10Vh","display_url":"bit.ly/13d10Vh"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350571882807959554","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@HJF29088181 Thanks for the feedback: we'll look into it!","id":"350571437934911490","created_at":"2013-06-28T11:08:38.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350569724070993920","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"350570516848984064"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1007144522"},{"text":"This morning we recommended new restrictions on the use of medicines containing #ergot derivatives: http://t.co/1kU9OsO0Fq","id":"350570875965284353","created_at":"2013-06-28T11:06:24.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/1kU9OsO0Fq","expanded_url":"http://bit.ly/10oWW1x","display_url":"bit.ly/10oWW1x"}],"hashtags":[{"start":80,"end":86,"tag":"ergot"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570875965284353","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"This morning we issued recommendations to manage risk of allergic reactions with IV #iron-containing medicines: http://t.co/g8Vnw4jUKB","id":"350570550797680640","created_at":"2013-06-28T11:05:07.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/g8Vnw4jUKB","expanded_url":"http://bit.ly/12442oy","display_url":"bit.ly/12442oy"}],"hashtags":[{"start":84,"end":89,"tag":"iron"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570550797680640","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"CMDh has endorsed PRAC recommendation on restrictions on the use of #flupirtine-containing medicines: http://t.co/IxfimmuCJe","id":"350570443163447296","created_at":"2013-06-28T11:04:41.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/IxfimmuCJe","expanded_url":"http://bit.ly/18k4IyE","display_url":"bit.ly/18k4IyE"}],"hashtags":[{"start":68,"end":79,"tag":"flupirtine"}],"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.3793,"type":"Organization","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570443163447296","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"CMDh has endorsed PRAC recommendation on restrictions on use of #codeine for pain relief in children: http://t.co/lLAnnWuENi","id":"350570302675238912","created_at":"2013-06-28T11:04:08.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/lLAnnWuENi","expanded_url":"http://bit.ly/12q6jP9","display_url":"bit.ly/12q6jP9"}],"hashtags":[{"start":64,"end":72,"tag":"codeine"}],"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.3333,"type":"Organization","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570302675238912","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"CMDh has endorsed PRAC recommendation on new safety advice for #diclofenac to minimise cardiovascular risks: http://t.co/lppIobjNuB","id":"350570194244075520","created_at":"2013-06-28T11:03:42.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/lppIobjNuB","expanded_url":"http://bit.ly/15MdAa0","display_url":"bit.ly/15MdAa0"}],"hashtags":[{"start":63,"end":74,"tag":"diclofenac"}],"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.3607,"type":"Organization","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570194244075520","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"350570076765818880","created_at":"2013-06-28T11:03:14.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":83,"end":94,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570076765818880","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to apply for our #vacancy for a resourcing assistant to support our IT office. Deadline: 12 July 2013: http://t.co/LjHMsWmR8d","id":"350570014786600960","created_at":"2013-06-28T11:02:59.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350570014786600960","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","id":"350569933006057473","created_at":"2013-06-28T11:02:39.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":57,"tag":"scientist"},{"start":69,"end":77,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350569933006057473","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more days to comment on our concept paper on the #toxicological risk of #veterinary medicines in #groundwater: http://t.co/Go7t6OEvwh","id":"350569801300705280","created_at":"2013-06-28T11:02:08.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":53,"end":67,"tag":"toxicological"},{"start":76,"end":87,"tag":"veterinary"},{"start":101,"end":113,"tag":"groundwater"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350569801300705280","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"350569724070993920","created_at":"2013-06-28T11:01:50.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":60,"end":71,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"350569724070993920","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: #Diabetes #news: Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia... http://…","id":"350569221555634176","created_at":"2013-06-28T10:59:50.000Z","entities":{"urls":{},"hashtags":[{"start":14,"end":23,"tag":"Diabetes"},{"start":24,"end":29,"tag":"news"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350569221555634176","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350568592921739264"}],"attachments":{"media_keys":{}}},{"text":"Some of our IT systems will be unavailable tomorrow. Sorry for any incovenience: http://t.co/zqcRWqsUAL","id":"350567247049277440","created_at":"2013-06-28T10:51:59.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/zqcRWqsUAL","expanded_url":"http://bit.ly/13d10Vh","display_url":"bit.ly/13d10Vh"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350567247049277440","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Recent advances in #Parkinson’s disease #genetics http://t.co/q8FiUP2qpp","id":"350566713475072000","created_at":"2013-06-28T10:49:52.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/q8FiUP2qpp","expanded_url":"http://bit.ly/14XSRTw","display_url":"bit.ly/14XSRTw"}],"hashtags":[{"start":37,"end":47,"tag":"Parkinson"},{"start":58,"end":67,"tag":"genetics"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350566713475072000","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350555731528925184"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: #Jobs New open positions added to the EASD Positions Vacant site: http://t.co/eTSQSuaWT3","id":"350563616761712641","created_at":"2013-06-28T10:37:34.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/eTSQSuaWT3","expanded_url":"http://goo.gl/Ido4M","display_url":"goo.gl/Ido4M"}],"hashtags":[{"start":14,"end":19,"tag":"Jobs"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350563616761712641","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350563448662405120"}],"attachments":{"media_keys":{}}},{"text":"@stevekshwang We are publishing the full highlights of the CHMP meeting at 12.00 noon UK time - in just over an hour. Watch this space.","id":"350552630025662464","created_at":"2013-06-28T09:53:54.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"stevekshwang","id":"1545818551"}],"annotations":[{"start":86,"end":87,"probability":0.7138,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350546504722812928","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"350548817638195200"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1545818551"},{"text":"RT @EFSA_EU: #EFSA Management Board addresses updated draft Multiannual Plan, boosting scientific cooperation: http://t.co/ZFeRcUmyR2","id":"350552292543578114","created_at":"2013-06-28T09:52:34.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ZFeRcUmyR2","expanded_url":"http://bit.ly/11GXzE2","display_url":"bit.ly/11GXzE2"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350552292543578114","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350547504510664704"}],"attachments":{"media_keys":{}}},{"text":"RT @eurordis: EURORDIS honoured to have supported five key #raredisease Recommendations published during EUCERD three-year mandate. http://…","id":"350552168094375937","created_at":"2013-06-28T09:52:04.000Z","entities":{"urls":{},"hashtags":[{"start":59,"end":71,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350552168094375937","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350544572629258241"}],"attachments":{"media_keys":{}}},{"text":"We've recommended new restrictions on use of medicines containing #ergot derivatives: http://t.co/1kU9OsO0Fq","id":"350546504722812928","created_at":"2013-06-28T09:29:34.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/1kU9OsO0Fq","expanded_url":"http://bit.ly/10oWW1x","display_url":"bit.ly/10oWW1x"}],"hashtags":[{"start":66,"end":72,"tag":"ergot"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"350546504722812928","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We've issued new recommendations to manage risk of allergic reactions with intravenous #iron-containing medicines: http://t.co/g8Vnw4jUKB","id":"350546204129624064","created_at":"2013-06-28T09:28:22.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/g8Vnw4jUKB","expanded_url":"http://bit.ly/12442oy","display_url":"bit.ly/12442oy"}],"hashtags":[{"start":87,"end":92,"tag":"iron"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350546204129624064","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Restrictions in the use of #flupirtine-containing medicines - CMDh has endorsed PRAC recommendation: http://t.co/IxfimmuCJe","id":"350545445229035520","created_at":"2013-06-28T09:25:21.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/IxfimmuCJe","expanded_url":"http://bit.ly/18k4IyE","display_url":"bit.ly/18k4IyE"}],"hashtags":[{"start":27,"end":38,"tag":"flupirtine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350545445229035520","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Restrictions on use of #codeine for pain relief in children – CMDh has endorsed PRAC recommendation: http://t.co/lLAnnWuENi","id":"350545241654304768","created_at":"2013-06-28T09:24:33.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/lLAnnWuENi","expanded_url":"http://bit.ly/12q6jP9","display_url":"bit.ly/12q6jP9"}],"hashtags":[{"start":23,"end":31,"tag":"codeine"}],"mentions":{},"annotations":[{"start":62,"end":65,"probability":0.3544,"type":"Person","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350545241654304768","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"New safety advice for #diclofenac – CMDh has endorsed PRAC recommendation to minimise cardiovascular risks: http://t.co/lppIobjNuB","id":"350544972681981954","created_at":"2013-06-28T09:23:28.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/lppIobjNuB","expanded_url":"http://bit.ly/15MdAa0","display_url":"bit.ly/15MdAa0"}],"hashtags":[{"start":22,"end":33,"tag":"diclofenac"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350544972681981954","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: #Research: Tiny Nanocubes - New method could improve drug development, optical sensors and more http://t.co/943nHDmD4h","id":"350540938021572610","created_at":"2013-06-28T09:07:27.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/943nHDmD4h","expanded_url":"http://1.usa.gov/14Bs4dE","display_url":"1.usa.gov/14Bs4dE"}],"hashtags":[{"start":11,"end":20,"tag":"Research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350540938021572610","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350538122938953728"}],"attachments":{"media_keys":{}}},{"text":"Two more weeks to apply for our #vacancy for a scientific administrator to work on #veterinary-medicine safety: http://t.co/UzsajTUBh9","id":"350528508822421504","created_at":"2013-06-28T08:18:03.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":83,"end":94,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350528508822421504","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to apply for our #vacancy for a resourcing assistant to support our IT office. Deadline: 12 July 2013: http://t.co/LjHMsWmR8d","id":"350528316056403968","created_at":"2013-06-28T08:17:17.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350528316056403968","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","id":"350528086019813379","created_at":"2013-06-28T08:16:22.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":57,"tag":"scientist"},{"start":69,"end":77,"tag":"quality"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350528086019813379","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two days left to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","id":"350527000949174272","created_at":"2013-06-28T08:12:04.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350527000949174272","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two days left to comment on our concept paper on the #toxicological risk of #veterinary medicines in #groundwater: http://t.co/Go7t6OEvwh","id":"350526917780307969","created_at":"2013-06-28T08:11:44.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":53,"end":67,"tag":"toxicological"},{"start":76,"end":87,"tag":"veterinary"},{"start":101,"end":113,"tag":"groundwater"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350526917780307969","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"350526721910521859","created_at":"2013-06-28T08:10:57.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":60,"end":71,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"350526721910521859","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Guidance for Industry:  Expedited Programs for Serious Conditions––Drugs and Biologics   http://t.co/hD1MmxEDHA","id":"350286272268472321","created_at":"2013-06-27T16:15:29.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/hD1MmxEDHA","expanded_url":"http://1.usa.gov/17aMBYO","display_url":"1.usa.gov/17aMBYO"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350286272268472321","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350286134020018176"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies http://t.co/E1hFYuWQnS","id":"350265310642843648","created_at":"2013-06-27T14:52:12.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/E1hFYuWQnS","expanded_url":"http://1.usa.gov/1cqBDih","display_url":"1.usa.gov/1cqBDih"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350265310642843648","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350265259363278849"}],"attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: Police, customs &amp; drug authorities in crackdown on online sales of illegal/counterfeit medicines http://t.co/wtEEciEE4g","id":"350263995523010560","created_at":"2013-06-27T14:46:58.000Z","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/wtEEciEE4g","expanded_url":"http://bit.ly/14wqOZ3","display_url":"bit.ly/14wqOZ3"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350263995523010560","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: It's here!!! EFPIA Annual Review 2012 &amp; Outlook 2013, covering developments affecting the pharma industry in Europe http://t.co/…","id":"350258000193265667","created_at":"2013-06-27T14:23:09.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":120,"end":125,"probability":0.989,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350258000193265667","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350257394669981696"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: #Diabetes ADA / EASD  statement concerning the use of Incretin Therapy and Pancreatic Disease - http://t.co/LjxEvnU8lB","id":"350257914868547586","created_at":"2013-06-27T14:22:49.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/LjxEvnU8lB","expanded_url":"http://easd.org/index.php?option=com_content&view=article&id=172","display_url":"easd.org/index.php?opti…"}],"hashtags":[{"start":14,"end":23,"tag":"Diabetes"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350257914868547586","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350255736695164929"}],"attachments":{"media_keys":{}}},{"text":"RT @EURLex: #Health Report from @EU_Commission: Better #Medicines for #Children @EU_Health  http://t.co/OB3ILLYvKB","id":"350250249148829696","created_at":"2013-06-27T13:52:21.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/OB3ILLYvKB","expanded_url":"http://owl.li/mraPU","display_url":"owl.li/mraPU"}],"hashtags":[{"start":12,"end":19,"tag":"Health"},{"start":55,"end":65,"tag":"Medicines"},{"start":70,"end":79,"tag":"Children"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":32,"end":46,"username":"EU_Commission","id":"157981564"},{"start":80,"end":90,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350250249148829696","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350247438738657280"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #EC decision on Network of bodies / nat. authorities responsible for #health technology assessment #HTA http://t.co/3FpIXdGg…","id":"350250030206169088","created_at":"2013-06-27T13:51:29.000Z","entities":{"urls":{},"hashtags":[{"start":15,"end":18,"tag":"EC"},{"start":84,"end":91,"tag":"health"},{"start":114,"end":118,"tag":"HTA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350250030206169088","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350245120165163009"}],"attachments":{"media_keys":{}}},{"text":"RT @EURLex: Rules provided by @EU_Commission for the Network of nat/l authorities responsible for #Health technology assessment http://t.co…","id":"350245470477627393","created_at":"2013-06-27T13:33:22.000Z","entities":{"urls":{},"hashtags":[{"start":98,"end":105,"tag":"Health"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":30,"end":44,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350245470477627393","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350244200899551233"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Proposal for fees payable to @EMA_News for #safety monitoring of #medicines in #EU adopted today http://t.co/i2TopgFVZc #pha…","id":"350244960710311937","created_at":"2013-06-27T13:31:20.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/i2TopgFVZc","expanded_url":"http://bit.ly/14cdZo3","display_url":"bit.ly/14cdZo3"}],"hashtags":[{"start":58,"end":65,"tag":"safety"},{"start":80,"end":90,"tag":"medicines"},{"start":94,"end":97,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":44,"end":53,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350244960710311937","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350243813492666368"}],"attachments":{"media_keys":{}}},{"text":"RT @MHRApress: MHRA nets UK record £12.2 million haul of counterfeit and unlicensed medicines http://t.co/2OitZF7VLb","id":"350244860856512515","created_at":"2013-06-27T13:30:56.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/2OitZF7VLb","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON287024","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":25,"end":26,"probability":0.6819,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350244860856512515","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350241554310496257"}],"attachments":{"media_keys":{}}},{"text":"RT @MHRApress: MHRA suspends use of hydroxyethyl starch (HES) drips http://t.co/ryev3YxTLA","id":"350244809048465409","created_at":"2013-06-27T13:30:44.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/ryev3YxTLA","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON287028","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350244809048465409","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350241420809994241"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies http://t.co/Qywh2yc5QU","id":"350237843790114817","created_at":"2013-06-27T13:03:03.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/Qywh2yc5QU","expanded_url":"http://1.usa.gov/1ahNx1l","display_url":"1.usa.gov/1ahNx1l"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9716,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350237843790114817","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350237739205144577"}],"attachments":{"media_keys":{}}},{"text":"RT @myESMO: Identifying the Drivers of Breast Cancer: new kinase targets http://t.co/VgzAf50ala #breastcancer","id":"350228800128303105","created_at":"2013-06-27T12:27:07.000Z","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/VgzAf50ala","expanded_url":"http://ow.ly/mqXt9","display_url":"ow.ly/mqXt9"}],"hashtags":[{"start":96,"end":109,"tag":"breastcancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350228800128303105","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350220664688492544"}],"attachments":{"media_keys":{}}},{"text":"RT @agesnews: 10 years of AGES: development 2002-2012 http://t.co/30eoC7H1rN &amp; new strategic priorities to 2015 http://t.co/VsaU7ALtdX","id":"350221967095369729","created_at":"2013-06-27T11:59:58.000Z","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/30eoC7H1rN","expanded_url":"http://de.slideshare.net/agesnews/va-06062013-frhauf-ages","display_url":"de.slideshare.net/agesnews/va-06…"},{"start":116,"end":138,"url":"http://t.co/VsaU7ALtdX","expanded_url":"http://www.ages.at/ages/ueber-uns/das-unternehmen/organisation/unternehmensstrategie/","display_url":"ages.at/ages/ueber-uns…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350221967095369729","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Class 2 Drug Alert (Action Within 48 Hours): Hydroxyethyl Starch (HES) products - B Braun Melsungen AG and Fre... http:/…","id":"350216675070705665","created_at":"2013-06-27T11:38:56.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350216675070705665","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350216410821165056"}],"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Pancreatic #Cancer: tackling the tumour by targeting its surroundings: With fewer than 5 percent of sufferers... http:…","id":"350212658353545216","created_at":"2013-06-27T11:22:59.000Z","entities":{"urls":{},"hashtags":[{"start":32,"end":39,"tag":"Cancer"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350212658353545216","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350209910975381505"}],"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Tackling the complications of childhood #Cancer treatment: While the diagnosis of any child or teenager with... http:/…","id":"350212586693865472","created_at":"2013-06-27T11:22:41.000Z","entities":{"urls":{},"hashtags":[{"start":61,"end":68,"tag":"Cancer"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350212586693865472","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350209908353933312"}],"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: #Hepatitis C virus - a 'master of minimalist design' http://t.co/bTutbBz5Do","id":"350207233574965250","created_at":"2013-06-27T11:01:25.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/bTutbBz5Do","expanded_url":"http://hms.harvard.edu/news/viral-architecture-6-13-13?utm_source=Twitter&utm_medium=Social%2Bpost&utm_campaign=socialflow","display_url":"hms.harvard.edu/news/viral-arc…"}],"hashtags":[{"start":18,"end":28,"tag":"Hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350207233574965250","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350206422451101696"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? http://t.co/BoZI9IyjAX","id":"350206476960272384","created_at":"2013-06-27T10:58:25.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/BoZI9IyjAX","expanded_url":"http://link.springer.com/article/10.1007/s00125-013-2904-2","display_url":"link.springer.com/article/10.100…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350206476960272384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350205965250994177"}],"attachments":{"media_keys":{}}},{"text":"RT @EASDnews: Insulin resistance in type 1 diabetes: what is ‘double #diabetes’ and what are the risks? - http://t.co/OWNW5mtCEv","id":"350196546572259328","created_at":"2013-06-27T10:18:57.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/OWNW5mtCEv","expanded_url":"http://link.springer.com/article/10.1007/s00125-013-2904-2","display_url":"link.springer.com/article/10.100…"}],"hashtags":[{"start":69,"end":78,"tag":"diabetes"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350196546572259328","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350194954599018496"}],"attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: The EU-funded DIOGENES project,shines a light on relationship between #genes,#diet and #obesity http://t.co/8cAkfIWmCn","id":"350196478330937344","created_at":"2013-06-27T10:18:41.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/8cAkfIWmCn","expanded_url":"http://owl.li/mqJeL","display_url":"owl.li/mqJeL"}],"hashtags":[{"start":84,"end":90,"tag":"genes"},{"start":91,"end":96,"tag":"diet"},{"start":101,"end":109,"tag":"obesity"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":[{"start":14,"end":35,"probability":0.3056,"type":"Other","normalized_text":"The EU-funded DIOGENES"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350196478330937344","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350194421700104192"}],"attachments":{"media_keys":{}}},{"text":"RT @agesnews: AGES RESEARCH FOCUS 2013 http://t.co/hajYQb1gtH Presentation of the Austrian Agency for Health and Food Safety http://t.co/M5…","id":"350196423482023936","created_at":"2013-06-27T10:18:28.000Z","entities":{"urls":[{"start":39,"end":61,"url":"http://t.co/hajYQb1gtH","expanded_url":"http://de.slideshare.net/agesnews/ages-en-research-2013","display_url":"de.slideshare.net/agesnews/ages-…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350196423482023936","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350193789756915713"}],"attachments":{"media_keys":{}}},{"text":"@BushbyKate @paulinemacco We're working together with @EUnetHTA on this. More info here: http://t.co/LQnKlrypm5","id":"350196209417322497","created_at":"2013-06-27T10:17:37.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/LQnKlrypm5","expanded_url":"http://bit.ly/1226jAB","display_url":"bit.ly/1226jAB"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"BushbyKate","id":"1216228962"},{"start":12,"end":25,"username":"paulinemacco","id":"325032216"},{"start":54,"end":63,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350191962692919298","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"350195436017041408"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1216228962"},{"text":"@paulinemacco @BushbyKate We don't deal with pricing or reimbursement - these are handled at a national level: http://t.co/Z7GrvbXFM6","id":"350194869676945408","created_at":"2013-06-27T10:12:17.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"paulinemacco","id":"325032216"},{"start":14,"end":25,"username":"BushbyKate","id":"1216228962"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"350191962692919298","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"350193398646448128"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"325032216"},{"text":"RT @WHO_Europe_TB: Epidemiology of tuberculosis in WHO European Region and public health response http://t.co/NHGZUwqvmT\n#TBChat @WHO_Europe","id":"350170132175257600","created_at":"2013-06-27T08:34:00.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/NHGZUwqvmT","expanded_url":"http://link.springer.com/article/10.1007%2Fs00586-012-2339-3","display_url":"link.springer.com/article/10.100…"}],"hashtags":[{"start":121,"end":128,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"},{"start":129,"end":140,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"350170132175257600","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"350163858297593856"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: New #Guidance for Industry: Expedited Programs for Serious Conditions - Drugs and Biologics http://t.co/Zg1aeDH6BM","id":"349920162188763137","created_at":"2013-06-26T16:00:42.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Zg1aeDH6BM","expanded_url":"http://1.usa.gov/1cmBvjU","display_url":"1.usa.gov/1cmBvjU"}],"hashtags":[{"start":23,"end":32,"tag":"Guidance"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349920162188763137","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349920066000793600"}],"attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Poison information centre pharmacist http://t.co/voaXLv0JI5 #newjob","id":"349912424146665473","created_at":"2013-06-26T15:29:57.000Z","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/voaXLv0JI5","expanded_url":"http://bit.ly/17fXeJP","display_url":"bit.ly/17fXeJP"}],"hashtags":[{"start":72,"end":79,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"349912424146665473","source":"TweetDeck","lang":"fr","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Intense negotiations on #EU budget for H2020 have concluded with a deal: Published on: 26-June-2013 After months... ht…","id":"349881886593654785","created_at":"2013-06-26T13:28:36.000Z","entities":{"urls":{},"hashtags":[{"start":45,"end":48,"tag":"EU"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349881886593654785","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349877222166888448"}],"attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: #BrainMonth retrospective on #eHealth: #EU #ICT research to treat neurological diseases &amp; even blindness #FP7 http://t.co/xMw…","id":"349881346656706562","created_at":"2013-06-26T13:26:28.000Z","entities":{"urls":{},"hashtags":[{"start":14,"end":25,"tag":"BrainMonth"},{"start":43,"end":51,"tag":"eHealth"},{"start":53,"end":56,"tag":"EU"},{"start":57,"end":61,"tag":"ICT"},{"start":123,"end":127,"tag":"FP7"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349881346656706562","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349858185554825216"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: US FDA does not need to issue Written Confirmations by 2 July 2013:  http://t.co/udZYAtDiH2","id":"349881028959141889","created_at":"2013-06-26T13:25:12.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/udZYAtDiH2","expanded_url":"http://bit.ly/1adLX0l","display_url":"bit.ly/1adLX0l"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":16,"end":18,"probability":0.719,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349881028959141889","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349843032130068480"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: Irish clinch deal on EU's 'Horizon 2020' research programme\nhttp://t.co/P22duGYC72","id":"349842807466364928","created_at":"2013-06-26T10:53:19.000Z","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/P22duGYC72","expanded_url":"http://m.euractiv.com/details.php?aid=528877","display_url":"m.euractiv.com/details.php?ai…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":34,"end":35,"probability":0.5415,"type":"Organization","normalized_text":"EU"},{"start":40,"end":51,"probability":0.4162,"type":"Other","normalized_text":"Horizon 2020"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349842807466364928","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349842425407225857"}],"attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: The indicative 9th Call text is now online! http://t.co/Awkzx8mUCj #frailty #ageing #pharmacovigilance #antimcrobial #resistance","id":"349842734334492672","created_at":"2013-06-26T10:53:02.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/Awkzx8mUCj","expanded_url":"http://bit.ly/1clE5GO","display_url":"bit.ly/1clE5GO"}],"hashtags":[{"start":79,"end":87,"tag":"frailty"},{"start":88,"end":95,"tag":"ageing"},{"start":96,"end":114,"tag":"pharmacovigilance"},{"start":115,"end":128,"tag":"antimcrobial"},{"start":129,"end":140,"tag":"resistance"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349842734334492672","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349842008996720640"}],"attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","id":"349842687895146498","created_at":"2013-06-26T10:52:51.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349842687895146498","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349841258379882496"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"Irish clinch deal on EU's 'Horizon 2020' research programme\" - @EU_H2020 #h2020 http://t.co/05xAm8uXBv","id":"349806601961615361","created_at":"2013-06-26T08:29:27.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/05xAm8uXBv","expanded_url":"http://bit.ly/19Benyw","display_url":"bit.ly/19Benyw"}],"hashtags":[{"start":85,"end":91,"tag":"h2020"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":75,"end":84,"username":"EU_H2020","id":"920249612329504768"}],"annotations":[{"start":33,"end":34,"probability":0.4552,"type":"Organization","normalized_text":"EU"},{"start":39,"end":50,"probability":0.3613,"type":"Other","normalized_text":"Horizon 2020"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349806601961615361","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349803970883108864"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Video about Safe Medicated #Feed for #Animal Producers is now available -   http://t.co/s93b9FopMt","id":"349565039973380096","created_at":"2013-06-25T16:29:34.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/s93b9FopMt","expanded_url":"http://1.usa.gov/1aKEaGd","display_url":"1.usa.gov/1aKEaGd"}],"hashtags":[{"start":48,"end":53,"tag":"Feed"},{"start":58,"end":65,"tag":"Animal"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349565039973380096","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349564655724797953"}],"attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: 1.9 billion for #brain research since the start of #FP7,in 2007 http://t.co/edYDMdIQM8 @DigitalAgendaEU #BrainMonth","id":"349565002665050113","created_at":"2013-06-25T16:29:25.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/edYDMdIQM8","expanded_url":"http://owl.li/mmZDJ","display_url":"owl.li/mmZDJ"}],"hashtags":[{"start":30,"end":36,"tag":"brain"},{"start":65,"end":69,"tag":"FP7"},{"start":118,"end":129,"tag":"BrainMonth"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":101,"end":117,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349565002665050113","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349562761430302720"}],"attachments":{"media_keys":{}}},{"text":"RT @FDACBER: #FDA Safety Communication: Boxed Warning for use of Hydroxyethyl Starch (HES) solutions in some settings http://t.co/8wDVLjioKQ","id":"349541009891401729","created_at":"2013-06-25T14:54:05.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/8wDVLjioKQ","expanded_url":"http://1.usa.gov/19nbkNM","display_url":"1.usa.gov/19nbkNM"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":[{"start":65,"end":83,"probability":0.3637,"type":"Product","normalized_text":"Hydroxyethyl Starch"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349541009891401729","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349540737794322433"}],"attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo We caution against long-term use of diclofenac in patients at high risk for cardiovascular disease http://t.co/UIlKMlkF0S","id":"349513644310142977","created_at":"2013-06-25T13:05:21.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/UIlKMlkF0S","expanded_url":"http://bit.ly/1chQ4VN","display_url":"bit.ly/1chQ4VN"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"349513644310142977","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Study shines a light on relationship between genes, diet and #Obesity: A project involving 29 partners from... http://…","id":"349488572274970624","created_at":"2013-06-25T11:25:43.000Z","entities":{"urls":{},"hashtags":[{"start":82,"end":90,"tag":"Obesity"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349488572274970624","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349485635054206976"}],"attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Clinical investigator http://t.co/gfxIQiweqV #newjob","id":"349488352287920128","created_at":"2013-06-25T11:24:51.000Z","entities":{"urls":[{"start":34,"end":56,"url":"http://t.co/gfxIQiweqV","expanded_url":"http://bit.ly/1aafqII","display_url":"bit.ly/1aafqII"}],"hashtags":[{"start":57,"end":64,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349488352287920128","source":"TweetDeck","lang":"es","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Association between dopaminergic medications &amp; nocturnal sleep in early-stage #Parkinson's http://t.co/73d0nrkj2X","id":"349488107768385538","created_at":"2013-06-25T11:23:52.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/73d0nrkj2X","expanded_url":"http://bit.ly/19ebbZv","display_url":"bit.ly/19ebbZv"}],"hashtags":[{"start":100,"end":110,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349488107768385538","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349483566935187459"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_TB: Strong recommendations on risk groups to screen for active #TB include close contacts and people living with #HIV http://t.co/…","id":"349487386079657985","created_at":"2013-06-25T11:21:00.000Z","entities":{"urls":{},"hashtags":[{"start":72,"end":75,"tag":"TB"},{"start":122,"end":126,"tag":"HIV"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349487386079657985","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349477103181373440"}],"attachments":{"media_keys":{}}},{"text":"RT @ECDC_TB: Very relevant for #EU: new @WHO guidelines on #screening active #TB set out principles for prioritizing risk groups http://t.c…","id":"349487333990604800","created_at":"2013-06-25T11:20:48.000Z","entities":{"urls":{},"hashtags":[{"start":31,"end":34,"tag":"EU"},{"start":59,"end":69,"tag":"screening"},{"start":77,"end":80,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":40,"end":44,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349487333990604800","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349476683541262336"}],"attachments":{"media_keys":{}}},{"text":"@EAHPtweet @GCessak @CPhAAPhC More info on what we're doing is explained here: http://t.co/90q7TAjF2L","id":"349486959615426562","created_at":"2013-06-25T11:19:18.000Z","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/90q7TAjF2L","expanded_url":"http://bit.ly/10YSIw3","display_url":"bit.ly/10YSIw3"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"},{"start":11,"end":19,"username":"GCessak","id":"556859372"},{"start":20,"end":29,"username":"CPhAAPhC","id":"122150936"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"349093617362669568","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"349457579392507904"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"203357203"},{"text":"@anitates @EU_Health For more information on what we've been doing for the past 5 years and links, see http://t.co/tSBCTtogGX","id":"349485508075847681","created_at":"2013-06-25T11:13:32.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/tSBCTtogGX","expanded_url":"http://bit.ly/12girlS","display_url":"bit.ly/12girlS"}],"hashtags":{},"mentions":[{"start":0,"end":9,"username":"anitates","id":"851439458"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349451939114795008","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"349476013002072065"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"851439458"},{"text":"Yesterday we released for public consultation our draft policy on access to #ctdata: http://t.co/I2UlBf4rTr","id":"349466396150865921","created_at":"2013-06-25T09:57:36.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/I2UlBf4rTr","expanded_url":"http://bit.ly/12drSSW","display_url":"bit.ly/12drSSW"}],"hashtags":[{"start":76,"end":83,"tag":"ctdata"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349466396150865921","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: More harmonised regulation for #veterinarymedicine will benefit many stakeholders: http://t.co/oU5wIOwOc3","id":"349465670825680897","created_at":"2013-06-25T09:54:43.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/oU5wIOwOc3","expanded_url":"http://bit.ly/120xgFL","display_url":"bit.ly/120xgFL"}],"hashtags":[{"start":47,"end":66,"tag":"veterinarymedicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349465670825680897","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349458968206245888"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: \"Children are not small adults. They require tailored medical treatments.\" Cssr. #Borg on #medicines for #children http://t.…","id":"349452361917411329","created_at":"2013-06-25T09:01:50.000Z","entities":{"urls":{},"hashtags":[{"start":96,"end":101,"tag":"Borg"},{"start":105,"end":115,"tag":"medicines"},{"start":120,"end":129,"tag":"children"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349452361917411329","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349451939114795008"}],"attachments":{"media_keys":{}}},{"text":"Yesterday we published guidance on how to submit single-assessment periodic safety update reports (#PSURs): http://t.co/46L8k5sqaK","id":"349447228785573888","created_at":"2013-06-25T08:41:26.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/46L8k5sqaK","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":[{"start":99,"end":105,"tag":"PSURs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"349447228785573888","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"@EU_Commission has published its report on 5 years of the #Paediatric Regulation: http://t.co/HhqmUB0bvt","id":"349446946383069185","created_at":"2013-06-25T08:40:19.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":[{"start":58,"end":69,"tag":"Paediatric"}],"mentions":[{"start":0,"end":14,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"349446946383069185","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}},"in_reply_to_user_id":"157981564"},{"text":"RT @EU_Consumer: Codex Alimentarius Commission (36th Session) Rome, 1 - 5 July 2013 - adnotated agenda available http://t.co/jOPle9AieF","id":"349446154976636929","created_at":"2013-06-25T08:37:10.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/jOPle9AieF","expanded_url":"http://bit.ly/1a7Me59","display_url":"bit.ly/1a7Me59"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349446154976636929","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349436838345322496"}],"attachments":{"media_keys":{}}},{"text":"Tomorrow is the deadline for comments on our revised guideline on periodic safety update reports (#PSURs): http://t.co/Lw4ork1lhR","id":"349201702337003520","created_at":"2013-06-24T16:25:48.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":98,"end":104,"tag":"PSURs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"349201702337003520","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: From electronic brains to the power of the mind…#fp7 http://t.co/XR08ZfEP4u","id":"349189679024836608","created_at":"2013-06-24T15:38:01.000Z","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/XR08ZfEP4u","expanded_url":"http://cordis.europa.eu/fetch?CALLER=OFFR_TM_EN&ACTION=D&RCN=11274&utm_source=twitterfeed&utm_medium=twitter","display_url":"cordis.europa.eu/fetch?CALLER=O…"}],"hashtags":[{"start":69,"end":73,"tag":"fp7"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349189679024836608","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349189619000147968"}],"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Treating neurological diseases and computers that see! #fp7 http://t.co/3bWbb7T4lK","id":"349189625249677315","created_at":"2013-06-24T15:37:48.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/3bWbb7T4lK","expanded_url":"http://cordis.europa.eu/fetch?CALLER=OFFR_TM_EN&ACTION=D&RCN=11275&utm_source=twitterfeed&utm_medium=twitter","display_url":"cordis.europa.eu/fetch?CALLER=O…"}],"hashtags":[{"start":76,"end":80,"tag":"fp7"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349189625249677315","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349189326095151104"}],"attachments":{"media_keys":{}}},{"text":"The EPAR for #Memantine ratiopharm, a #generic of #Ebixa for #Alzheimer's disease, is now available: http://t.co/ZnCa5EjLXU","id":"349169114998247424","created_at":"2013-06-24T14:16:18.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/ZnCa5EjLXU","expanded_url":"http://bit.ly/17rBqP6","display_url":"bit.ly/17rBqP6"}],"hashtags":[{"start":13,"end":23,"tag":"Memantine"},{"start":38,"end":46,"tag":"generic"},{"start":50,"end":56,"tag":"Ebixa"},{"start":61,"end":71,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349169114998247424","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more day to comment on our revised #pharmacovigilance guideline on periodic safety update reports (#PSURs): http://t.co/Lw4ork1lhR","id":"349169026901098497","created_at":"2013-06-24T14:15:57.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"},{"start":103,"end":109,"tag":"PSURs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349169026901098497","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: The Food and Drug Administration (USA) approves 1st blood test that identifies strains of the hepatitis C virus http://t.…","id":"349168863054794752","created_at":"2013-06-24T14:15:18.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":[{"start":52,"end":54,"probability":0.7207,"type":"Place","normalized_text":"USA"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349168863054794752","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349168797682380800"}],"attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: What's the link between #hepatitis and vitamin D? http://t.co/eVKpPtWpQ1","id":"349166666686541825","created_at":"2013-06-24T14:06:35.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/eVKpPtWpQ1","expanded_url":"http://www.vitamindcouncil.org/vitamin-d-news/vitamin-d-and-hepatitis-b-virus-whats-the-link/","display_url":"vitamindcouncil.org/vitamin-d-news…"}],"hashtags":[{"start":42,"end":52,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349166666686541825","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349143350034702338"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO will contribute to 50% of all countries having a nat. strategy for pandemic preparedness by 2015 - vs 40% in 2011 http://t.co/…","id":"349166452504412160","created_at":"2013-06-24T14:05:44.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349166452504412160","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349139160063414274"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: Report on #medicines for #children: more #research, more availability &amp; more info compared w/ 5ys ago http://t.co/7G98sE…","id":"349165459083501569","created_at":"2013-06-24T14:01:47.000Z","entities":{"urls":{},"hashtags":[{"start":29,"end":39,"tag":"medicines"},{"start":44,"end":53,"tag":"children"},{"start":60,"end":69,"tag":"research"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349165459083501569","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349127331769626625"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: EC | Medicines for children: more research, more availability and more information compared with 5 years ago http://t.co/SBUlh…","id":"349165425512284161","created_at":"2013-06-24T14:01:39.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349165425512284161","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349125487286697984"}],"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA approves #Vibativ for hospitalized patients with bacterial  pneumonia\nhttp://t.co/SOmVMIuqXr","id":"349165352418160640","created_at":"2013-06-24T14:01:21.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/SOmVMIuqXr","expanded_url":"http://1.usa.gov/10fwrLP","display_url":"1.usa.gov/10fwrLP"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":33,"end":41,"tag":"Vibativ"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349165352418160640","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349124852109676544"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: 1st #EU report on #medicines for #children five years since the Paediatric Regulation came into force http://t.co/nFZTGvI0z5…","id":"349165319484489729","created_at":"2013-06-24T14:01:14.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/nFZTGvI0z5","expanded_url":"http://bit.ly/10fwh76","display_url":"bit.ly/10fwh76"}],"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":33,"end":43,"tag":"medicines"},{"start":48,"end":57,"tag":"children"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":79,"end":99,"probability":0.3335,"type":"Organization","normalized_text":"Paediatric Regulation"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349165319484489729","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349124484772548608"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: What progress for #children #medicines in #EU in the last 5 years? More research, info &amp; medicines available http://t.co/3aU…","id":"349165226790354945","created_at":"2013-06-24T14:00:51.000Z","entities":{"urls":{},"hashtags":[{"start":33,"end":42,"tag":"children"},{"start":43,"end":53,"tag":"medicines"},{"start":57,"end":60,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349165226790354945","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349119761281593344"}],"attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Sign up for the IMI 9th Call webinars: http://t.co/fbmJroW6Qn #pharmacovigilance #frailty #antimicrobial #resistance","id":"349164995579346945","created_at":"2013-06-24T13:59:56.000Z","entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/fbmJroW6Qn","expanded_url":"http://bit.ly/10fmMVv","display_url":"bit.ly/10fmMVv"}],"hashtags":[{"start":74,"end":92,"tag":"pharmacovigilance"},{"start":93,"end":101,"tag":"frailty"},{"start":102,"end":116,"tag":"antimicrobial"},{"start":117,"end":128,"tag":"resistance"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349164995579346945","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349106597424934913"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: International drug shortages summit releases recommendations -- read all about it!  http://t.co/pxpxGsXBDq via @CPhAAPhC","id":"349164687977492482","created_at":"2013-06-24T13:58:43.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/pxpxGsXBDq","expanded_url":"http://bit.ly/183ZMO7","display_url":"bit.ly/183ZMO7"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":124,"end":133,"username":"CPhAAPhC","id":"122150936"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349164687977492482","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"349093617362669568"}],"attachments":{"media_keys":{}}},{"text":"We've just released for public consultation our draft policy on access to clinical-trial data: http://t.co/I2UlBf4rTr","id":"349155507224862721","created_at":"2013-06-24T13:22:14.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/I2UlBf4rTr","expanded_url":"http://bit.ly/12drSSW","display_url":"bit.ly/12drSSW"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"349155507224862721","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"European Commission has just published its report on Paediatric Regulation: http://t.co/HhqmUB0bvt","id":"349152739596570624","created_at":"2013-06-24T13:11:14.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":18,"probability":0.711,"type":"Organization","normalized_text":"European Commission"},{"start":53,"end":73,"probability":0.4186,"type":"Other","normalized_text":"Paediatric Regulation"}]},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"349152739596570624","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"We have just published our guidance on submission of single assessment PSURs: published http://t.co/46L8k5sqaK","id":"349152154247888897","created_at":"2013-06-24T13:08:55.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/46L8k5sqaK","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"349152154247888897","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA obtains waiver from European Commission to facilitate #export for U.S. pharmaceutical manufacturers. http://t.co/fp…","id":"348109791446577154","created_at":"2013-06-21T16:06:56.000Z","entities":{"urls":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":78,"end":85,"tag":"export"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":44,"end":62,"probability":0.5507,"type":"Organization","normalized_text":"European Commission"},{"start":90,"end":93,"probability":0.8594,"type":"Place","normalized_text":"U.S."}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348109791446577154","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348109725818302464"}],"attachments":{"media_keys":{}}},{"text":"RT @Eu2P: Last chance to apply for the Eu2P Master 2013-2014 session. Application period closes on June 23rd.\nhttp://t.co/EjFzGJ2cQ4","id":"348090184371408896","created_at":"2013-06-21T14:49:01.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/EjFzGJ2cQ4","expanded_url":"http://www.eu2p.org/diplomas-offer/master?prm=tw20130621","display_url":"eu2p.org/diplomas-offer…"}],"hashtags":{},"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"annotations":[{"start":39,"end":54,"probability":0.3905,"type":"Other","normalized_text":"Eu2P Master 2013"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348090184371408896","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348089990238052353"}],"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers http://t.co/4nomXiAVBY","id":"348074525616906241","created_at":"2013-06-21T13:46:48.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/4nomXiAVBY","expanded_url":"http://1.usa.gov/19Yi04q","display_url":"1.usa.gov/19Yi04q"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9173,"type":"Organization","normalized_text":"FDA"},{"start":36,"end":54,"probability":0.7479,"type":"Organization","normalized_text":"European Commission"},{"start":81,"end":84,"probability":0.9308,"type":"Place","normalized_text":"U.S."}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348074525616906241","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348073103408103424"}],"attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Memantine ratiopharm, a #generic of #Ebixa for #Alzheimer's disease: http://t.co/ZnCa5EjLXU","id":"348038530603311104","created_at":"2013-06-21T11:23:46.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ZnCa5EjLXU","expanded_url":"http://bit.ly/17rBqP6","display_url":"bit.ly/17rBqP6"}],"hashtags":[{"start":42,"end":52,"tag":"Memantine"},{"start":67,"end":75,"tag":"generic"},{"start":79,"end":85,"tag":"Ebixa"},{"start":90,"end":100,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"348038530603311104","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Identifying the drivers of breast #Cancer: Information on what causes breast cancer is sorely lacking, making... http:…","id":"348036850134421504","created_at":"2013-06-21T11:17:05.000Z","entities":{"urls":{},"hashtags":[{"start":55,"end":62,"tag":"Cancer"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348036850134421504","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348036775811375104"}],"attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: EC fines 9 #Pharma companies for 146 mio for pay-for-delay deals to not supply cheaper generics. Read our blog at: http://t.…","id":"348035824278978560","created_at":"2013-06-21T11:13:01.000Z","entities":{"urls":{},"hashtags":[{"start":26,"end":33,"tag":"Pharma"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348035824278978560","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348035773959913472"}],"attachments":{"media_keys":{}}},{"text":"One week left to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","id":"348033092985954305","created_at":"2013-06-21T11:02:10.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348033092985954305","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on our concept paper on the #toxicological risk of #veterinary medicines in #groundwater: http://t.co/Go7t6OEvwh","id":"348033033321984000","created_at":"2013-06-21T11:01:55.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":53,"end":67,"tag":"toxicological"},{"start":76,"end":87,"tag":"veterinary"},{"start":101,"end":113,"tag":"groundwater"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"348033033321984000","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"348032942481735680","created_at":"2013-06-21T11:01:34.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":61,"end":72,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348032942481735680","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @EMCDDA: Hepatitis C treatment for injecting drug users: http://t.co/sxUKz2KPQH","id":"348015934436409344","created_at":"2013-06-21T09:53:59.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/sxUKz2KPQH","expanded_url":"http://www.emcdda.europa.eu/topics/pods/hepatitis-c-treatment","display_url":"emcdda.europa.eu/topics/pods/he…"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":12,"end":22,"probability":0.3569,"type":"Organization","normalized_text":"Hepatitis C"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348015934436409344","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"348001488431378432"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #EPSCO You can watch live @EUCouncil discussions on #tobacco #cliniclatrials &amp; #medicaldevices at http://t.co/UxjnFsP2t2","id":"348015764239941632","created_at":"2013-06-21T09:53:18.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/UxjnFsP2t2","expanded_url":"http://video.consilium.europa.eu/","display_url":"video.consilium.europa.eu"}],"hashtags":[{"start":15,"end":21,"tag":"EPSCO"},{"start":67,"end":75,"tag":"tobacco"},{"start":76,"end":91,"tag":"cliniclatrials"},{"start":98,"end":113,"tag":"medicaldevices"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":41,"end":51,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348015764239941632","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347999908541915137"}],"attachments":{"media_keys":{}}},{"text":"RT @GCessak: EPSCO Council on Health today. On the agenda: tobacco, clinical trials of medicines, medical devices: http://t.co/6n9K1hr8eW","id":"348015744598032384","created_at":"2013-06-21T09:53:13.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/6n9K1hr8eW","expanded_url":"http://ow.ly/mdSOf","display_url":"ow.ly/mdSOf"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348015744598032384","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347998826415652864"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #EPSCO Council on #Health today. #Tobacco, #clinicaltrials, #medicaldevices &amp; #eHealth on agenda http://t.co/qw4fwD1C9b via …","id":"348015613463105536","created_at":"2013-06-21T09:52:42.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/qw4fwD1C9b","expanded_url":"http://ow.ly/mdSOf","display_url":"ow.ly/mdSOf"}],"hashtags":[{"start":15,"end":21,"tag":"EPSCO"},{"start":33,"end":40,"tag":"Health"},{"start":48,"end":56,"tag":"Tobacco"},{"start":58,"end":73,"tag":"clinicaltrials"},{"start":75,"end":90,"tag":"medicaldevices"},{"start":97,"end":105,"tag":"eHealth"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"348015613463105536","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347998184565522433"}],"attachments":{"media_keys":{}}},{"text":"Register now for our workshop on developing medicines for #multiplesclerosis on 17 October #MS: http://t.co/kqAJ2PTuY8","id":"347991715984060416","created_at":"2013-06-21T08:17:45.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/kqAJ2PTuY8","expanded_url":"http://bit.ly/15n0obe","display_url":"bit.ly/15n0obe"}],"hashtags":[{"start":58,"end":76,"tag":"multiplesclerosis"},{"start":91,"end":94,"tag":"MS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347991715984060416","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"A public consultation on the Community herbal monograph for #Curcuma xanthorrhiza (Javanese turmeric) is now open: http://t.co/HNIHUx4fbI","id":"347991282448224256","created_at":"2013-06-21T08:16:01.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/HNIHUx4fbI","expanded_url":"http://bit.ly/19UHwHz","display_url":"bit.ly/19UHwHz"}],"hashtags":[{"start":60,"end":68,"tag":"Curcuma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347991282448224256","source":"Twitter Web Client","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One more week to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","id":"347990970563981312","created_at":"2013-06-21T08:14:47.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347990970563981312","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"One week left to comment on our concept paper on the #toxicological risk of #veterinary medicines in #groundwater: http://t.co/Go7t6OEvwh","id":"347989755511848960","created_at":"2013-06-21T08:09:57.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":53,"end":67,"tag":"toxicological"},{"start":76,"end":87,"tag":"veterinary"},{"start":101,"end":113,"tag":"groundwater"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347989755511848960","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our priority list of off-patent #paediatric medicines for possible future study funding: http://t.co/CUPDf8K3Wc","id":"347989069705404416","created_at":"2013-06-21T08:07:14.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":61,"end":72,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347989069705404416","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA approves first genotyping test for patients with hepatitis C virus http://t.co/0JcIXmTzHY","id":"347751166886686720","created_at":"2013-06-20T16:21:53.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/0JcIXmTzHY","expanded_url":"http://1.usa.gov/195V3fX","display_url":"1.usa.gov/195V3fX"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8301,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347751166886686720","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347751093515730947"}],"attachments":{"media_keys":{}}},{"text":"RT @WHO: Latest update on Middle East Respiratory Syndrome http://t.co/K11uQ7972v #MERS","id":"347729130474840064","created_at":"2013-06-20T14:54:19.000Z","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/K11uQ7972v","expanded_url":"http://goo.gl/MxAqR","display_url":"goo.gl/MxAqR"}],"hashtags":[{"start":82,"end":87,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":26,"end":57,"probability":0.6324,"type":"Other","normalized_text":"Middle East Respiratory Syndrome"}]},"public_metrics":{"retweet_count":64,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347729130474840064","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347729089358094336"}],"attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: FDA Announces Public Meeting on Expanded Drug Supply Chain Authorities   http://t.co/tfYzxw3G4u","id":"347725979764002816","created_at":"2013-06-20T14:41:48.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/tfYzxw3G4u","expanded_url":"http://1.usa.gov/11PUXQY","display_url":"1.usa.gov/11PUXQY"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":[{"start":21,"end":23,"probability":0.9316,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347725979764002816","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347725757797253121"}],"attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Our #EU Health newsletter fresh out from the press. Focus on #health and enlargement - #Croatia #EU28 http://t.co/eDJaZhTkYq","id":"347725963397840896","created_at":"2013-06-20T14:41:44.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/eDJaZhTkYq","expanded_url":"http://bit.ly/12drmQA","display_url":"bit.ly/12drmQA"}],"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":76,"end":83,"tag":"health"},{"start":102,"end":110,"tag":"Croatia"},{"start":111,"end":116,"tag":"EU28"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347725963397840896","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347725415047106562"}],"attachments":{"media_keys":{}}},{"text":"RT @EFPIA: The Pharmaceutical Industry in figures - Edition 2013 http://t.co/JMcWFgALAl http://t.co/kP4bgKG5r3","id":"347724274267717633","created_at":"2013-06-20T14:35:02.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/JMcWFgALAl","expanded_url":"http://bit.ly/13Vg5sv","display_url":"bit.ly/13Vg5sv"},{"start":88,"end":110,"url":"http://t.co/kP4bgKG5r3","expanded_url":"http://www.efpia.eu","display_url":"efpia.eu"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347724274267717633","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347720179121274881"}],"attachments":{"media_keys":{}}},{"text":"Registration is open for our workshop on developing medicines for #multiplesclerosis on 17 October #MS: http://t.co/kqAJ2PTuY8","id":"347716061845655552","created_at":"2013-06-20T14:02:24.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/kqAJ2PTuY8","expanded_url":"http://bit.ly/15n0obe","display_url":"bit.ly/15n0obe"}],"hashtags":[{"start":66,"end":84,"tag":"multiplesclerosis"},{"start":99,"end":102,"tag":"MS"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347716061845655552","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @USPharmacopeia: #Job #USP is hiring a Senior VP of #Chemical #Medicines. #PhD required. Info &amp; how to apply: http://t.co/Oa6CrfJ4Oq","id":"347708940500484096","created_at":"2013-06-20T13:34:06.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Oa6CrfJ4Oq","expanded_url":"http://bit.ly/122fQf8","display_url":"bit.ly/122fQf8"}],"hashtags":[{"start":20,"end":24,"tag":"Job"},{"start":25,"end":29,"tag":"USP"},{"start":55,"end":64,"tag":"Chemical"},{"start":65,"end":75,"tag":"Medicines"},{"start":77,"end":81,"tag":"PhD"}],"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347708940500484096","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347708767829381120"}],"attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Information day on new good distribution practice for human medicines http://t.co/Ad9pXgz7SH","id":"347708905595469824","created_at":"2013-06-20T13:33:57.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Ad9pXgz7SH","expanded_url":"http://www.aemps.gob.es/eventosCongresos/inspe-Farma/2013/J_buena-practica-distribucion.htm","display_url":"aemps.gob.es/eventosCongres…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"347708905595469824","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"text":"RT @myESMO: From Guidelines to Personalised Medicine: Personalised Therapies for Urological Cancers http://t.co/oC3no71eWU #EMUC13","id":"347708642738450432","created_at":"2013-06-20T13:32:55.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/oC3no71eWU","expanded_url":"http://ow.ly/mdCxW","display_url":"ow.ly/mdCxW"}],"hashtags":[{"start":123,"end":130,"tag":"EMUC13"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347708642738450432","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347706954187173889"}],"attachments":{"media_keys":{}}},{"text":"RT @esno_web: ESNO member European Medicines Agency Human Scientific Comm. Working Party Healthcare Professionals.(HCPWP). More at http://t…","id":"347708419429511169","created_at":"2013-06-20T13:32:01.000Z","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"esno_web","id":"1185837546"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"347708419429511169","source":"TweetDeck","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347704436262567936"}],"attachments":{"media_keys":{}}},{"text":"We've launched a public consultation on the Community herbal monograph for #Curcuma xanthorrhiza (Javanese turmeric): http://t.co/HNIHUx4fbI","id":"347698095720628225","created_at":"2013-06-20T12:51:00.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/HNIHUx4fbI","expanded_url":"http://bit.ly/19UHwHz","display_url":"bit.ly/19UHwHz"}],"hashtags":[{"start":75,"end":83,"tag":"Curcuma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"347698095720628225","source":"bitly bitlink","lang":"en","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}}]
